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Abstract 
During this project we developed a new and more efficient system for creating tissue 
engineered tubes for small diameter blood vessel implants. Our objectives were to find a method 
for seeding cells in a tubular shape and provide nutrients and waste removal throughout growth. 
We achieved these objectives by designing a custom bioreactor system that provides a sterile 
environment for tissue tube growth. The outcome of this project provided proof that scaffold-free 
tissue tubes can be created using our method. 
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1.0 Introduction 
Coronary heart disease is a major malady facing the population of the United States which 
causes approximately one in every five deaths. In 2006 alone, over 16 million Americans 
suffered from some manifestation of coronary heart disease, including myocardial infarction, 
acute coronary syndrome and angina pectoralis. The American Heart Association predicts that 
this number will have risen by 785,000 victims in 2009 alone. In 2006, 448,000 coronary artery 
bypass graft (CABG) procedures were performed, with a mean cost of approximately $100,000 
per procedure.
1
 There is currently a critical need for a suitable small diameter (<6mm outer 
diameter) coronary artery analog for CABG procedures and, to a lesser extent, vascular 
replacement in the lower extremities.
2
 Currently, there are three standard sources which can be 
used to replace these vessels. These sources are: autologous grafts, synthetic blood vessel 
replacements, and tissue engineered blood vessels.  
The present state of the art for CABG procedures is the use of autologous vessels directly 
from the patient
2
. These vessels are typically extracted from either the internal mammary artery 
in the chest, or the saphenous vein in the posterior lower leg.
2
 The major advantage of using 
autologous vessels is that, since they are retrieved directly from the patient, there is no possibility 
of immune rejection. The major limiting factors for this method of blood vessel replacement are 
the availability of blood vessels and the age of the patient. Since many patients who receive one 
bypass graft will eventually return for a second procedure,
1
 there is a limited length of blood 
vessel which can be retrieved autologously. Additionally, the majority of patients who 
experience coronary artery diseases are in their mid-to-late 60’s1 and therefore the available 
autologous vessels are typically afflicted with atherosclerosis. These atherosclerotic blood 
vessels do not have sufficient elastic properties to resist the pressures a bypass graft would be 
subjected to in vivo.
3
 
A second method used for synthetic grafts within the body is completely synthetic blood 
vessels. These grafts have been successfully applied to large diameter applications, such as in the 
aorta, but have shown poor performance in small diameter applications due to their high 
susceptibility to thrombosis.
2
 As a result, many researchers have focused their studies on non-
synthetic materials for small diameter replacements. 
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The third small diameter artery analogs that are being explored are tissue engineered blood 
vessels (TEBV’s).2,4  Several approaches have been taken to produce viable blood vessels using 
tissue engineering techniques.  Two distinct approaches that have been studied are scaffold-
based and scaffold-free tissue engineered blood vessels. A scaffold is a material on which cells 
are seeded in order to provide structural and mechanical support for the cells. The scaffold may 
or may not degrade over time and has been successfully used to form a variety of cell types into 
blood vessels.
5
 Scaffold-free approaches to developing tissue engineered blood vessels are a 
more recent, though increasingly popular, topic of research in the field of tissue engineering. 
Examples of scaffold-free approaches include bioprinting,
6
 tissue-sheet rolling,
4
 and growth on 
collagen matrices.
7
  The benefits of scaffold-free blood vessel engineering may include improved 
mechanical properties, stronger cellular adhesion within the tissue, and the elimination of 
byproducts from the degradation of a scaffold. These approaches, along with other methods of 
tissue engineering will be examined in detail in the literature review. 
Currently, scaffold-free tissue engineering is resource intensive, expensive and requires a 
large amount of direct manipulation by researchers.
8
 In this project we aim to alleviate the 
amount of time and effort required to grow tissue engineered blood vessels.  Additionally, we 
will attempt to increase the rate at which viable blood vessels can be grown for either clinical or 
research applications. 
The overall goal of this project is to design a system that efficiently and reproducibly 
grows rat aortic smooth muscle cells (RSMCs) into a viable cylindrical construct on a tubular 
mandrel. In order to achieve this goal, we have divided our project into three separate objectives. 
The first objective is to design a tubular mandrel on which we can seed cells. The mandrel must 
both promote cell adhesion and allow for easy removal of the final tubular construct once the 
cells have proliferated. The second objective is to develop a method by which we can stimulate 
cells to attach to the mandrel and proliferate. The third and final objective is to incorporate our 
cell seeding process and mandrel design into a bioreactor which can be used to grow viable 
tissue engineered blood vessels with limited user effort. 
In order to accomplish the goals of our project, we began by approaching our three 
objectives individually. We started by devising conceptual designs by which we could 
accomplish the three top objectives of our project. After a period of extensive brainstorming and 
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idea development, we began to consolidate our concepts into complete preliminary designs. In 
the end we developed four preliminary designs that we decided warranted further testing. We 
then devised a set of quantitative metrics, which identified for us what would define a design that 
met our objectives. Each of our four designs was compared to these metrics and rated on how 
well we believed it would meet them based on preliminary testing. Additionally, for these four 
designs, we devised simple experiments that tested the efficacy of various important aspects of 
the design. Over time we determined that different designs were not feasible and eliminated 
designs to narrow our focus. In the end, we determined that one of our designs was the most 
promising based on our objectives, constraints and initial tests and chose to pursue that design 
further. We also continued testing a secondary design to ensure that we had a failsafe if our main 
design was unsuccessful. In the final stage of our project, we tested our entire apparatus to show 
that it produces tissue tubes that fall into our predefined metrics, design constraints, and 
objectives.  
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2.0 Background 
This section will describe the background and current state of the art in the literature for 
various aspects of our project.  We will begin by discussing the clinical significance of small 
diameter vascular grafts.  Next we will discuss the general anatomy of a blood vessel and the 
molecular mechanisms necessary for cell attachment and later release of completed tissue tubes.  
Finally, we will discuss currently marketed small diameter vessels, the state of the art for tissue 
engineered blood vessels and the various types of bioreactors that are used in the lab to date.  
2.1. Clinical Significance and Blood Vessel 
Pathology 
Diseases affecting blood vessels are a prominent cause of medical problems throughout the 
world and, since 1997, have been determined to be the most common cause of death in the 
United States.
1
 There is a wide range of diseases that can affect the blood vessels in the body, 
one of the most common being atherosclerosis. Atherosclerosis is a condition in which blood 
vessels are partially blocked by plaque buildup, which disrupts the flow of blood to parts of the 
body. The initial symptoms may not be obvious to patients or doctors; however a symptomless 
patient with atherosclerosis can rapidly degenerate into myocardial infarction or stroke. 
Atherosclerosis can cause coronary artery disease, carotid artery disease, and peripheral arterial 
disease, which are all problematic diseases as explained below. 
 Peripheral artery disease occurs when blood vessels that supply blood to the legs, arms, 
and pelvis become blocked. This condition can cause numbness, pain, and occasionally 
infections of the body. Carotid artery disease is caused when the carotid artery becomes blocked. 
A problematic condition that can arise due to carotid artery disease is a stroke, which involves 
cutting off blood supply to the brain and is the third most common cause of death in the United 
States each year. Finally, coronary artery disease is a blockage of the coronary artery and this is 
the main cause of myocardial infarction, leading to ischemic death of a portion of heart muscle.  
 
 According to the National Heart, Lung and Blood Institute, Coronary Artery Disease 
(CAD) was the leading cause of death in the United States in 2005.
1
 There were nearly 500,000 
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deaths in the United States in 2005, making up about one fifth of all deaths in the US. 
Additionally, 16,800,000 people were victims of angina (chest pain due to coronary artery 
disease), heart attack, or CAD in general. This represents approximately 8.8% of the male 
population and 9.0% of the female population in the United States.
1
  
 Based on the high percentage of the population affected by coronary artery disease and 
the severe, and sometimes fatal, problems relating to CAD, treatment options will be of critical 
importance in the future of medicine in the United States. A current solution to this problem is 
coronary artery bypass grafting, (CABG), in which vascular grafts are surgically implanted to 
bypass the blockage and restore flow. Graft sources include synthetic, autologous, or tissue 
engineered grafts. In order to understand the various aspects of these grafts, we must first 
examine the anatomy and physiology of blood vessels. This project will focus on the field of 
tissue engineering, though a firm understanding of current technology is important in 
understanding the relevance of the project as a whole. 
2.2. Structure and Function of Blood Vessels 
Blood vessels are tubular structures that supply blood to all of the tissues and organs of the 
body. Blood vessels have an important physiological role and are responsible for the transport 
and regulation of blood flow throughout the body.  Although blood vessels can be divided into 
several different vessel types, all blood vessels are composed of the same three cellular layers.  
In this section, we will first discuss the basic blood vessel anatomy and the different 
physiological characteristics of each cell layer.  Next, we will discuss the different blood vessel 
types and how they differ.  Finally, since our project will focus on smooth muscle cells, we will 
discuss the physiology behind the contraction of smooth muscle. 
2.2.1. Blood Vessel Structure 
All vascular tissue is composed of three anatomically distinct cellular layers.  These layers 
are, from innermost to outermost, the tunica intima, the tunica media and the tunica adventitia.  
Each of these layers has specific structural and functional characteristics which allow the blood 
vessels to effectively carry out their role. 
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The tunica intima is the only layer of vascular tissue which comes into contact with blood.  
The tunica intima is formed exclusively of endothelial cells which are only one layer thick.  
These cells function to allow nutrient flow into and out of the lumen of the vessel and prevent 
blood clotting factors from coagulating and stopping blood flow. 
The tunica media is composed of many layers of smooth muscle cells (SMCs).  These cells 
provide the primary mechanical support for the vessel and help to prevent rupture due to blood 
pressure.  Additionally, this layer allows the vessel to be contracted or dilated by the nervous 
system to alter blood flow to different areas of the body.  This gives the brain precise control 
over what parts of the body are receiving the most nutrients and oxygen at any given time. 
The final vascular layer, the tunica adventitia, is responsible for connecting blood vessels 
to the surrounding tissue and providing additional mechanical support.  This layer is composed 
primarily of loosely woven collagen fibers and can also contain small capillaries to provide 
nutrients to the outer layers of the tunica media. 
2.2.2. Blood Vessel Types 
Although all types of blood vessels have the same three basic layers, the prominence of 
different layers differs between vessel types.  Vasculature can be divided into five different 
blood vessel types: arteries, arterioles, capillaries, venules, and veins.  During somatic 
circulation, the arteries and arterioles are the first vessels to receive blood from the heart and thus 
have a thick tunica media to resist bursting.  These vessels have thick elastic walls which can 
withstand high pressures.  The veins and venules, on the other hand, receive blood at the end of 
the circulatory cycle and thus have lower internal pressures.  As a result, veins and venules have 
much thinner walls then arteries.  Finally, capillaries are the thinnest vessels and are only 
composed of the tunica intima.  Capillaries facilitate the transfer of nutrients and gases into body 
tissues and rely on surrounding tissues to support them structurally 
2.2.3. Smooth Muscle Physiology 
Since our project focuses specifically on growing the tunica media layer of the blood 
vessel, it is very important that we understand the physiological mechanisms controlling smooth 
muscle contraction.  When smooth muscles contract, an electrochemical action potential is 
propagated through the cell membrane and into the sarcoplasmic reticulum; resulting in a 
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chemical pathway which activates cell contraction.  In vivo, this pathway is typically activated 
by the sympathetic nervous system.
11
  During sympathetic activation, a neurotransmitter 
activates the electrochemical action potential in the muscle cells.  Previous studies have also 
found that muscle contraction can be activated by solutions with concentrated potassium ions. 
This process works because the high extracellular concentration of potassium ions causes the 
spontaneous depolarization and contraction of the smooth muscle cells.
12
 The contractile nature 
of smooth muscle cells can be used in applications for vascular replacement.  
2.3. Vascular Replacements 
 There are three prevalent vascular grafts that are currently being used or researched. 
These three main groups are synthetic grafts, autologous grafts, and tissue engineered grafts. 
Synthetic grafts are made of materials that are not naturally found in the body. Autologous grafts 
are blood vessels harvested from other areas of the patient’s body and used to replace diseased 
vessels. In contrast, tissue engineered grafts are grown in a variety of ways by utilizing current 
cell seeding methods and creating an in vitro environment similar to that of the body. The current 
approaches for vascular grafts each have their own advantages and disadvantages as will be 
discussed in the following sections. 
2.3.1. Autologous Grafts 
 Autologous grafts are currently the ―gold standard‖ for vascular grafts and are almost 
always used in situations where a CABG procedure is required. The main advantage of an 
autologous graft is that they inherently possess the properties necessary for use as a blood vessel. 
Furthermore, since the graft is directly from the patient, there is little risk of rejection of the 
blood vessel. One disadvantage of an autologous graft is that patients who require bypass grafts 
may not have a blood vessel suitable for transplant. Another disadvantage is that this procedure 
requires a secondary surgery to remove the donor blood vessel, resulting in increased 
hospitalization time and risk of complications for the patient.  
2.3.2. Synthetic Grafts 
 Synthetic vascular grafts are one option for patients that do not have a blood vessel 
available for transplantation. These grafts consist completely of materials that are not naturally 
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found in the body, which can lead to clotting, infection, and rejection by the body’s immune 
system. Although they have been proposed as an alternative to autologous grafts, synthetic grafts 
are not used extensively for small diameter applications because of their high susceptibility to 
clotting.
13
 
2.3.3. Tissue Engineered Vascular Grafts 
There are a variety of methods that have been researched in order to produce tissue 
engineered blood vessels (TEBV). Some of these methods include the rolling of tissue sheets to 
form a tubular structure, the growth of cells on a scaffold, and the growth of cell tubes without 
the use of a scaffold. The rolling method involves culturing cells as a sheet, and once they have 
reached a sufficient thickness, removing the sheet and rolling it into a tube form. Scaffolds are 
structures that provide support to growing cells and are advantageous because they encourage the 
growth of cells into three dimensional tissues, allowing the cells to be manipulated into a variety 
of structures. Scaffolds may degrade as the cells proliferate in order to eventually have a 
completely cell based graft. Ideally, the cells will grow and synthesize extracellular matrix 
(ECM) at approximately the same rate as the polymer scaffold is resorbed, thus creating a 
structurally stable tissue tube.
14
 Finally, scaffold-free mandrel based designs have also been 
researched and will be the primary focus of this study. A mandrel, in this application, is a 
cylindrical structure on which a tissue engineered blood vessel will be grown and/or supported. 
Mandrels may be made of a variety of materials depending on their exact application. Because 
the tissue engineered blood vessel will be supported by the mandrel, the outer diameter of the 
mandrel directly determines the inner diameter of the TEBV that is grown.  
This section will examine the advantages and disadvantages of different methods of 
growing tissue engineered vascular grafts as described in literature to date.  The two main 
categories examined are scaffold-based and scaffold-free grafts.  Scaffold materials and designs 
currently in use can be broadly divided into three separate groups: natural scaffold materials, 
permanent synthetic scaffolds and resorbable synthetic scaffolds.  Additionally we will discuss 
scaffold free methods in detail, as this method is the primary focus of our project.   
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Scaffold Based Grafts 
 The use of scaffolds in tissue engineering has proven to be a successful method for 
growing many different types of tissue. Various research groups have used scaffolds to culture 
cells and create multilayer tissue engineered blood vessels. One challenging aspect of using a 
scaffold is determining its degradation rate and matching it to an appropriate cellular growth rate. 
This is important because without the support of the scaffold, the blood vessel may burst under 
arterial pressures in vivo.  
Biological Scaffold Materials 
Biological scaffold materials have been used in many studies to date. These scaffolds can 
either consist of decellularized ECM harvested from natural sources,
15
 or be composed of natural 
protein scaffolds that have been grown in vitro.
14
  
Decellularized ECM is advantageous in comparison to other materials simply because it is 
harvested directly from biological sources and therefore does not typically cause fibrotic 
encapsulation.
16
 Problems exhibited by these materials include: structural degeneration, 
breakdown of vascular walls over time, and overall insufficient mechanical properties.
15
 
Additionally, these scaffolds produce vessels that can cause infections, form aneurisms, or 
induce thrombosis.
14
 
Scaffolds composed of natural proteins, such as collagen, fibrin, or fibronectin are ideal for 
cell adhesion because they are naturally synthesized by cells as part of ECM structures in the 
body. Historically, the first adhesive gels were made from collagen.
17
 Collagen gels have been 
shown to yield a high percentage of circumferentially aligned cells, which closely resembles 
alignment in natural blood vessels.
14
 Additionally, since collagen gels have been FDA approved 
for implantation in other applications, they can more easily be approved for similar applications. 
In some collagen studies, it has been shown that the resultant blood vessels cannot withstand 
vascular pressures that are found in the body.
18
 In an attempt to improve these results, collagen 
has been cross linked with elastin providing the vessels with a greater elasticity and better 
mechanical properties. Although the collagen/elastin gels did provide better structural 
characteristics than pure collagen gels, they still could not withstand the pressures experienced 
by small diameter arteries.
14
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In more recent studies, collagen gels have been replaced with fibrin gels.
18
 Fibroblasts, 
when implanted in fibrin gels, produce more ECM than in collagen. This has resulted in a more 
mechanically stable structure. In one study, blood vessels grown on fibrin scaffolds were 
successfully implanted in the jugular veins of sheep
19
. Despite the increased mechanical 
integrity, fibrin gels have still fallen short of providing the mechanical properties necessary for 
small diameter artery implantation without extensive mechanical conditioning. 
Synthetic scaffolds 
To date, many studies have examined the use of synthetic scaffolds for the growth of 
arterial substitutes. For these vessels, a biodegradable scaffold is used which is designed to be 
implanted with the vessel and degrade over time. More recently, some studies have begun to 
examine methods for growing vessels on bioinert materials, which do not integrate with the 
tissues or vessels that are grown.  
Like natural scaffolds, synthetic scaffolds have been developed which support smooth 
muscle cell growth and ECM production. These arterial substitutes have shown great promise as 
viable arterial replacements.
15
 Niklason et al. used poly glycolic acid (PGA) scaffolds in a 
pulsatile pressure bioreactor for 8 weeks.
20
 The vessels resulting from this work were able to 
withstand burst pressures of greater than 2000 mmHg. In a similar study, Shum-tim et al. grew a 
mixture of smooth muscle and endothelial cells on a copolymer of PGA and 
polyhydroxyalkanoate (PHA).
21
 The resulting vessels were implanted into lamb aortas with a 
100% patency rate. The major problem facing this area of research is the long preparation time 
necessary for vessel growth if the scaffolds are allowed to grow cells prior to implantation. Due 
to the urgency of most clinical cases that would require a tissue engineered blood vessel, a more 
than 2 month waiting period from cell harvest to blood vessel implantation is not plausible.
15
 
Scaffold Free Vascular Grafts 
In the scaffold free approach, bioinert synthetic mandrels are typically used as cylindrical 
structures around which different cellular constructs are grown. This process differs from using 
synthetic scaffolds in that a mandrel made of a synthetic material provides support to the cells 
and tissues but does not integrate with the cells.  L’Heureux et al., the pioneers in the field of 
scaffold free vessel engineering, used a poly tetra-fluoro-ethylene (PTFE) mandrel wrapped in a 
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smooth muscle sheet then an outer fibroblast layer. After the cells had generated the two tissue 
layers, the PTFE was removed and the lumen of the vessel was seeded with endothelial cells. 
The vessels were then implanted in animal models. These initial vessels only resulted in about 
50% patency rates after one week.
22
  
Other researchers have used a novel approach to growing scaffold free tubes. Chue et al. 
have grown blood vessels in the bodily cavities of dogs with some success. In this method, 
several different inert polymer materials were arthroscopically implanted into either the 
peritoneal or pleural cavities of dogs.
23
 These tubes were then explanted 3 weeks later, and found 
to be coated in a sheet of living tissue. After removal, the tissue tubes were tested for burst 
pressure strength and found to burst at greater than 2500 mmHg, a value similar to that of a 
canine femoral artery. Despite its apparent success, this approach to tissue engineering blood 
vessels presents several problems. First and foremost, the blood vessels must be implanted in the 
patient’s body for three weeks before they can be used—requiring a second surgery. Secondly, 
despite their phenomenal burst strength, the vessels grown in this method are not composed of 
smooth muscle, and therefore do not respond to medications or hormones in the same way as 
natural blood vessels.
23
 
Another novel approach to scaffold free tissue engineering that has recently been published 
is the work of Norrotte et al.
6
 In this work, several lines of cellular spheroids are ―printed‖ by a 
mechanical device in a three dimensional agarose gel. As these cellular spheroids grow, they 
form into a tubular construct which is composed entirely of cellular matter. The resulting blood 
vessel produced by bioprinting has not yet been shown to have the mechanical properties 
necessary for implantation.
6
 
Researchers such as L’Heureux et al. have rolled cell sheets to form tissue engineered 
blood vessels that have adequate mechanical properties.
4
 As a result, current methods being used 
specifically for engineering cell sheets have the potential to be applied to tissue engineering of 
blood vessels.  
 Another application of rolled cell sheet tissue engineering is Cytograft’s tissue 
engineered blood vessel. Cytograft’s process involves taking a small dermal tissue sample from 
the patient and culturing these cells in sheet form, then using the sheets to mold into a tube. 
Researchers from Cytograft have shown that the rolled blood vessels have comparable, if not 
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stronger, strength than natural blood vessels, despite not using the SMC’s typically seen in blood 
vessels. Possibly the most valuable attribute of this type of tissue engineering is that the TEBVs 
are made completely of the patient’s own cells and therefore will not be rejected. The main 
disadvantage of this system is the length of time taken to grow the actual blood vessel. With a six 
to nine month growth time before implantation is possible, Cytograft’s product is not an ―off-the-
shelf‖ product.24 
2.4. Current Practices 
Current practice in the Rolle Lab involves coating a silicone mandrel with pre-polymerized 
collagen in order to promote cellular adhesion.
7
  This is accomplished by injecting collagen into 
a custom-made poly-tetrafluoroethylene (PTFE) shell using a syringe.  This process is shown in 
Figure 2-1.  The collagen coated silicon mandrel is then seeded with cells by suspending it by its 
two ends from a silicon washer. The tube is then placed upside down in a hanging drop of media. 
The entire cell seeding process is depicted in Figure 2-2.   Next, the collagen mandrel and cell 
assembly is incubated until the cells proliferate enough to form a confluent tube. Removal of the 
vessel from the mandrel is accomplished by manually stretching the silicon tube and sliding the 
vessel off of the mandrel. This method leaves much to be desired by way of vessel wall 
uniformity, and mechanical integrity of the vessel upon removal.  Additionally, this method is 
extremely time and resource intensive. 
 
Figure 2-1: A picture of collagen being injected into a custom made PTFE shell 
to form a silicon coating.  This process is part of the current method for 
creating TEBVs.7 
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Figure 2-2: Pictorial depiction of the hanging drop method.7 
2.5. Bioreactors 
A bioreactor is any device that supports a biologically active environment. In the culture 
chamber, environmental conditions such as pH, temperature, pressure, nutrient supply, and waste 
removal, are tightly controlled to maximize culture growth and viability. Bioreactors are used in 
many applications such as industrial fermentation processing, wastewater treatment, food 
processing, the pharmaceutical industry and tissue engineering. 
In the field of tissue engineering, bioreactors are used as a means for the production of 
tissue constructs. Worldwide costs for the substitution of organs are estimated to be 350 billion 
USD.
24
  Successfully engineered tissue constructs could one day replace allograft materials such 
as bone or cartilage. The tissue engineered constructs would eliminate the inherent risk of 
pathogenic infections or graft rejection from the allograft materials.
25
 Tissue engineered 
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constructs could also replace artificial implants made from synthetic materials which have 
problems with lifespan, biocompatibility, and inflammation.  
Bioreactors have been used for thousands of years for the fermentation of alcoholic 
beverages. While yeast and bacteria are encased within a tough cell wall and are able to 
withstand environmental stresses, mammalian cells are much more delicate. In particular, 
mammalian cells require a complex nutrient medium for growth and cannot withstand strong 
shear stresses. The physiological shear stresses in vascular tissue can vary widely. For example, 
the shear stresses in large arteries away from branches experience from 2-8 Pa. Vein capillaries 
on the other hand experience shear stresses between 0.1-0.6 Pa.
25
 Most mammalian cells also 
require some sort of substrate surface to attach to in order to proliferate. 
23
 
2.5.1. Types of Bioreactors 
Bioreactors can be classified by the type of flow produced or the mixing characteristics 
within the culture chamber. The two main groups of reactors are the stirred tank reactor and the 
tubular flow reactor. In the stirred tank reactor, shown in Figure 2-3, nutrient medium is pumped 
into the inlet, stirred by some sort of mixer, and then pumped out of the exit. Ideally, the 
concentration of nutrient medium, gases and other substrates would be uniform throughout the 
entire tank. This means that any cell within the chamber would always have the same 
concentration of nutrients and gases as other cells regardless of the position within the chamber. 
There would also be no ―dead pockets‖ where there is a lack of nutrients or oxygen or any solid 
aggregates on the surface. 
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Figure 2-3: A schematic example of a stirred tank bioreactor. This design 
constantly stirs the media solution to keep nutrients evenly concentrated 
throughout the culture chamber26 
A different type of bioreactor, known as the tubular flow reactor, is shown in Figure 2-4. In 
the tubular flow reactor, nutrient medium is pumped into the inlet, agitated by a rotor, and then 
pumped out through the exit. Many tubular reactors are used in the production of proteins by 
mammalian cells. Unlike the stirred tank reactor, the concentration levels of nutrients in the 
medium vary throughout the length of the reactor. The concentration of nutrients and gases will 
be high at the inlet and low at the outlet, while the concentration of metabolites will be low at the 
inlet and high at the outlet. The exact concentrations of nutrients and gases depends on the length 
of the reactor, metabolic activity of the cells, amount of cells and the initial concentrations of the 
medium. For this reason, the length of a tubular reactor is limited as the concentration gradient of 
nutrients, gases, and metabolites inhibit cell growth towards the end of the culture chamber.
26
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Figure 2-4: A schematic example of a tubular flow bioreactor. In this reactor, 
the  medium flows linearly through the reactor from end to end at a 
constant rate26 
One specific type of tubular reactor is the rotating wall vessel bioreactor, as shown in 
Figure 2-5. The rotation rate of the bioreactor is computed to balance out the gravitational force 
Fg, the drag force Fd, and the centrifugal force Fc. This creates a micro-gravity like environment 
in which cells undergo free fall as the bioreactor chamber rotates. The specific example shown in 
Figure 2-5 is the high aspect ratio vessel (HARV) developed by NASA’s Johnson Space Center. 
In this reactor, the vessel walls rotate at a rate of 12-15 rpm. Nutrient medium is constantly 
pumped through the inlet and then flows down the center of the chamber and diffuses outward. 
The rotation of the chamber also serves as a way to agitate and mix the nutrient solution. The 
cells within the culture chamber undergo very small shear stresses, while the nutrient medium 
has a high mass transfer rate and high oxygen concentrations. As a result, cells grown in rotating 
wall vessel bioreactors grow in concentrations that are denser compared to cells grown in 
conventional stirred-tank bioreactors.
26
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Figure 2-5: Rotating Wall Vessel Bioreactor. In this bioreactor, rotation puts 
cells into a state of constant free fall causing them to form aggregates27 
 
2.5.2. Conditions Inside Bioreactors 
The environment within a bioreactor culture chamber must be tightly controlled to produce 
viable and healthy cells. The temperature, pH and salt levels of the medium must be maintained 
at optimal levels for cell proliferation. The culture chamber must be sterilized to prevent outside 
contaminants from entering the culture chamber. Bacteria, fungi, and possibly even pathogens 
can easily destroy a culture of interest if allowed entry in the chamber. Antibiotics are usually 
added to prevent growth of unwanted organisms. Growth factors are sometimes added to induce 
differentiation of certain cell types. The nutrients within the medium such as glucose must be 
maintained at high enough concentrations to supply the proliferating cell cultures with 
nourishment. Metabolites such as lactase must also be controlled to prevent high concentrations 
from inhibiting cell growth.
26
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In addition to the environmental conditions within a culture chamber, other problems with 
bioreactors must be addressed to create optimal levels of growth and successful cell cultures. In 
the human body, the majority of cells are within 100 µm of a capillary.
26
 These capillaries are 
able to supply the cells with their nutrient needs and additionally to remove cellular waste. This 
is a major problem in bioreactors, as the lack of natural vascularization of tissues within cell 
cultures greatly limits growth and aggregate density. Without proper vascularization for the mass 
transfer requirements of the cells, necrotic centers form within the cell aggregates once their 
diameters become too large.
27
 Hypoxic conditions of the media also lead to necrotic damage 
since mammalian cell cultures require high levels of oxygen. Therefore the critical thickness for 
mammalian cell cultures is 100-200 µm due to the limitations of oxygen diffusion.
27
  
2.6. Related Patents 
To date, there are several patents which have been developed that are relevant to our 
project.  The patents in this section were chosen for their relation to bioreactor design and as 
representatives of the current industry standards.  We will discuss the various patents and 
describe the novel concepts that they present. 
2.6.1. US Patent 7,510,866 B2 
Patent US 7,510,866 B2 is a hybrid bioreactor for cell culture that is able to apply both 
compressive strain and shear strain. Application of compressive strain promotes the proliferation 
of cells while shear strain promotes the differentiation of cells. This would be helpful in any 
bioreactor design. The device, shown in Figure 2-6, has multiple reactor tube assemblies to grow 
multiple cultures simultaneously. The shear stress is applied by rotating the tube assemblies 
while the compressive stress is applied by continuously moving the assemblies vertically. The 
reactor tube assemblies are also able to support a porous culture mandrel that is able to grow 
cells that adhere to the culture mandrel. If a non porous culture mandrel is not used, then the 
reactor is also able to grow a culture of cells in suspension instead.
28
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Figure 2-6: Hybrid Reactor for cell culture consisting of multiple rotating 
culture chambers connected to a single media reservoir28 
2.6.2. US Patent 7,456,019 
US patent 7,456,019 is a three-dimensional cell to tissue development process that is able 
to grow living mammalian cells with minimal damage from shear stress. The culture chamber, as 
shown in Figure 2-7, the vessel wall, labeled 27, rotates around the horizontal axis at variable 
rotation rates to negate gravitational flow. The mandrel material, labeled 23, also rotates around 
the horizontal axis. The process also includes applying a varying electromagnetic force that is 
driven by a pulsed square wave exerting magnetic field that ranges from 0.05 to 0.5 gauss. The 
time varying electromagnetic force is able to significantly increase cell growth and 
differentiation.
23
 The very slow fluid shear stress in the device allows the cell cultures to grow in 
high densities and into higher order 3-dimensional multi-cellular tissue-like structures compared 
to other culturing processes. The patent contains additional means to maintain the environment 
of the culture chamber, as shown in Figure 2-8, such as introducing oxygen, removing wastes, 
and others.
29  
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Figure 2-7: Vertical Cross-section of Culture Chamber for Tubular Flow 
Bioreactor. Both the inner mandrel and outer vessel rotate to negate 
gravitational flow.29 
 
Figure 2-8: Flow Diagram for US 7,456,019 showing the major components 
which connect to the reactor vessel and the tissue culture chamber29 
2.6.3. US Patent 7,144,727 
Patent 7,144,727 titled ―culture chamber for biologicals‖ is a culture chamber, shown in 
Figure 2-9 that is composed of one or more membranes that prevent flow of high molecular 
weight substances. Nutrient medium is pumped through the membrane into the chamber while 
the metabolites are transported away from the chamber though the membrane and out of the 
chamber outlet. The molecular weight cut-off membranes allow the nutrients and metabolites to 
pass through while keeping the culture cells within the chamber. Any other compounds passing 
through the chamber must have a molecular weight lower than the molecular weight cut-off for 
the membrane. The device allows for the possibility of having reusable chambers or a chamber 
housing that contains disposable bioreactor bags. The chamber is attached to a roller drive that 
rotates the culture chamber around its axis, producing a micro-gravity like environment within 
the culture chamber.
30
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Figure 2-9: Culture chamber for a tubular flow reactor. A molecular weight 
membrane is used to keep the cells within the inner chamber while media 
solution can flow out.30  
2.7. Gaps in the Current Technology 
Current technology used for the creation of tissue engineered blood vessels is highly labor 
intensive and inefficient.  It is the aim of this MQP to devise a more efficient and less labor 
intensive approach to forming tissue tubes without a scaffold.  This approach should be more 
efficient and effective than the method currently used in the Rolle Lab. By paying specific 
attention to the mandrel material, it may be possible to seed the cells on the mandrel safely and 
evenly, and ultimately remove the mandrel so as not to damage the vessel once it is ready for 
mechanical conditioning or testing. Ideally, the process will involve minimal labor from the user 
and be partially or fully automated. Our primary focus lies in promoting cellular adhesion to a 
mandrel, creating a confluent tissue tube, and controlling the detachment of the tube from the 
mandrel at will.  
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3.0 Project Strategy 
This Chapter will outline the strategy we used to approach our project. We will begin by 
presenting the initial client statement that we received at the onset of the project. Next we will 
discuss the methods we used to devise reasonable project objectives and eventually the revised 
problem statement that we developed based on our objectives. At the end of this chapter, we will 
describe the overall approach we took in completing this project.  
3.1. Initial Client Statement 
 The initial client statement was given to the design team by the client, Dr. Marsha Rolle, 
at the beginning of the design process. The initial statement is vague and needed revisions in 
order to help the team develop a device that best met the client’s needs and wants for her 
laboratory. The initial, unrevised client statement is as follows: 
 
The goal of your project is to design a device that will allow seeding and culture of cells 
on tubular mandrels to generate tissue engineered blood vessels. Silicone tubing has been used 
as a mandrel material due to its flexibility, which is useful for cyclic mechanical loading to 
condition tissue constructs prior to transplantation. Our lab has used a “hanging drop” method 
to facilitate cell seeding
7
, but this method is time consuming and inefficient. Others have shown 
that implanting silicone tubing in the peritoneal cavity of recipient animals (“in vivo 
bioreactor”) results in cell adhesion and tissue encapsulation of mandrel materials, and the 
resulting tissue is strong enough to be implanted in the recipient’s vascular system. Your task is 
to design an “in vitro bioreactor” that will achieve a similar result. 
 
 Through client interviews, the selection of specific objectives, and the weighting of these 
objectives, the design team was better able to understand which functions and qualities were 
specifically important to the client. 
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3.2.  Objectives and Constraints 
 In order to create a measurable description of the development of the design, a thorough 
list of objectives was created. Due to the wide scope of the project, the objectives were divided 
into three categories: the mandrel, the cell seeding method, and the bioreactor. Additionally, a 
list of constraints was developed; if the device does not meet any of the constraints it cannot be 
used.  
3.2.1. Constraints 
 Since the use and success of the device relies heavily on the constraints, concern for them 
is crucial in the design process. The team identified a few constraints for this design. The first 
constraint is cost as the team was given a budget of $624.00. This limitation includes all costs 
including design costs and final product costs. The next constraint is time. The design 
development, production, and testing must be completed by Project Presentation Day, which is 
on April 22
nd
 2010. In regards to the device itself, materials must be biocompatible and the must 
be able to be sterilized. Finally, the device must be safe for the users of the device and all 
possible risks must be eliminated or at least minimized. 
3.2.2. Objectives of the Mandrel 
 The development of an appropriate mandrel is imperative to the success of this design. 
Since the mandrel will be in direct contact with the cells, it’s material and structural properties 
are very important. The bulleted list below shows the objectives that were developed for the 
mandrel: 
 Cells stick to mandrel material 
 TEBV can be easily removed after growth 
 Keeps TEBV ends open 
 TEBV grows on mandrel but does not integrate with mandrel material 
 Minimize material costs 
These objectives are all important for the success of the mandrel itself. Cells must be able 
to stick to the mandrel in order to form a confluent tube of cells. However, cells cannot be 
integrated into the mandrel and must be easily removed after growth in order to provide a viable 
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tubular structure after removal. The ends must remain open in order to enable fluid flow through 
the vessel. Finally, the material costs should be minimized to ensure that the final design will be 
within budget. 
3.2.3. Objectives of the Cell Seeding Method 
There is a wide variety of cell seeding methods that could be used in this design in order to 
ensure that cells will stick to the mandrel and to make a usable tissue tube. These objectives can 
be seen below: 
 Cells must stick evenly to all sides of mandrel 
 Cells must grow and support themselves with ECM 
 High success rate for adequate cell seeding  
The objectives above are all important in relation to promoting cell adhesion to the 
mandrel. In order to create a mechanically functional tissue tube, cells must adhere evenly to the 
surface of the mandrel so there are no weak areas in the engineered blood vessel. The cells must 
be able to proliferate and produce extracellular matrix (ECM) in order to provide the mechanical 
properties of a natural blood vessel. Finally, there must be a high success rate of cells adhering to 
the mandrel. It would not be efficient or effective to place millions of cells into the device and 
only have 10% of the cells actually adhere to the mandrel and grow into a blood vessel. 
3.2.4. Objectives of the Bioreactor 
The final category of objectives determined by the team was the objectives of the 
bioreactor. In order to make the final product easy to use, the team would like to develop a more 
automated process to ultimately grow tissue engineered blood vessels. These objectives are listed 
below: 
 Supply media to the cells, while removing wastes 
 Small enough to fit in an incubator 
 Maintain physiological environment 
 The main goal of the bioreactor is to culture the cells in a physiological environment. 
This can be achieved by making the bioreactor small enough to fit in an incubator, which will 
control the temperature along with other conditions, such as pH and humidity.  This will allow 
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cells to survive and proliferate. The bioreactor will also simplify the process of feeding the cells 
by supplying media to the cells and removing the waste the cells produce. 
3.2.5. Weighted Objectives 
 While all of the objectives are important in the development of this device, some 
objectives are of higher priority than others. The objectives were weighted by both the design 
team and the client using pair wise which can be seen in Appendix A. 
As mentioned above, the objectives were divided into three primary categories: the 
mandrel objectives, the cell seeding objectives, and the bioreactor objectives. The importance of 
these groups of objectives was weighted before the sub-objectives were weighted. The mandrel 
material was found to be the most important aspect of the project. This is due to the poor 
performance of current mandrel materials in the field of scaffold-free tissue tube engineering. 
The cell seeding method was the next most important aspect of the project to the client. This is 
important because ensuring that the cells are seeded into the device properly will allow for better 
properties upon the growth of a tissue tube. Finally, the bioreactor is the least important aspect of 
the project to the client. The automated feeding is not necessary to the success of the design; 
however it will increase the ease of the design. The decision-making process used by the team 
will be described for each of these categories.  
 The most important objective for the design of the mandrel structure was ensuring that 
the cells would not integrate with the mandrel. This is important because the motivation for this 
project is to design an approach to scaffold-free blood vessel engineering. If the cells were to 
integrate with the mandrel, this will not meet the objective of eliminating foreign materials in the 
TEBV. The next most important objective was determined to be the biocompatibility of the 
mandrel material. Selecting a biocompatible mandrel material ensures that the cells will not die 
due to contact with the mandrel. Other less important objectives included a mandrel that can be 
sterilized easily, keeps the tissue tubes open at the end, and can be easily removed after tissue 
tube growth.  Finally, the two least important objectives were that the cells are able to stick to the 
mandrel material and the minimization of material costs. The adherence of cells to the mandrel is 
not an overly important objective because the mandrel can be coated to promote cell adhesion or 
the cells may not need to initially adhere to the mandrel. Alternative options for cellular adhesion 
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to the mandrel will be discussed in the Alternative Designs chapter. The material cost was not of 
great concern to the client and was therefore ranked lowest. These weighted objectives ultimately 
aided the design team in prioritizing and focusing efforts on the most important aspects of the 
mandrel. 
 The second group of objectives to be evaluated was the cell seeding method. The most 
important objective of the cell seeding method was that the cells were able to grow and support 
their own extracellular matrix. This is very important to the success of the design because the 
tissue tubes will not have a scaffold to support them; therefore the support of the ECM is 
necessary in providing the structure the tube needs. The next most important objective was that 
the cells stick evenly to the mandrel. A uniform coverage is crucial in the engineering of tissue 
tubes due to the high pressures found in these vessels. If one portion of the tube wall is 
significantly thinner than another portion, this could lead to aneurysm formation or vessel 
rupture. Finally, the objective for cell seeding that was ranked lowest was the success rate of the 
process. This objective was likely ranked lowly because the current process is already inefficient 
and any improvement seen in the new approach will be of use to the client. A novel cell seeding 
method is necessary in this research in order to create a complete device that will be both 
successful and user friendly. 
 The final group of objectives that was weighted by the team involved the bioreactor. The 
most important objective was found to be the bioreactor’s ability to maintain a physiological 
environment. This is clearly important in ensuring the growth and survival of the cells. The next 
most important was the capacity of the bioreactor to supply media to the cells. The least 
important objective of the bioreactor was the small size of the device. Ideally the device should 
be small enough to fit in an incubator in order to create proper cell culture conditions. Our client 
did not believe the size of the device was overly important as long as it met the other objectives 
and constraints set forth. By meeting these weighted objectives, the design team will better meet 
the needs of the client and will create a more successful device.  
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3.3. Revised Client Statement 
 After considering the constraints and objectives developed by the team, the client 
statement was revised to provide a clear, specific description of the needs of the client. The 
revised client statement is as follows: 
 
The goal of this project is to design a device that will use tubular mandrels to produce 
tissue engineered blood vessels composed of cultured cells and a cell-derived extracellular 
matrix. An appropriate mandrel material should be used to allow for the efficient seeding of cells 
and removal of the blood vessel after a given cultivation period. Current methods being utilized 
involve coating a silicone mandrel with an adhesive biomaterial. Ideally the process would not 
involve any coatings. The generated blood vessels should be within 0.5 – 4 mm in inner diameter 
and 3 – 5 cm in length. The system should be easily modified to support a variety of vessel sizes. 
The device will incorporate a bioreactor that will simulate a physiological environment 
conducive for cell growth by maintaining temperature and pH, supplying nutrients and oxygen, 
removing waste, and preventing contamination. 
3.4. Project Approach 
Once the objectives and constraints for the three different sections of the device were 
decided upon, ranks were assigned to each of the three sections. Different methods and materials 
were brainstormed for each portion of the design as can be seen in our function means trees in 
Appendix B. After functions-means trees were created, the feasibility of various combinations of 
means were discussed and combined to develop four preliminary designs.  These four designs 
were then conceptually tested for their ability to meet our objectives and constraints. 
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4.0 Alternative Designs 
In order to ensure that our design was the most promising design that we could complete 
within our constraints, we first had to create, analyze, and compare various design concepts.  In 
this section we will begin by discussing the target benchmarks for our tissue tubes along with the 
functions of our device and the means by which we can accomplish them.  We will then discuss 
our four preliminary designs, show our models for each design, and discuss the benefits and 
limitations of each design.  Finally, we will discuss the feasibility that each of our designs will be 
able to achieve our project objectives while remaining within budget and time constraints. 
4.1. Needs Analysis 
In order to better understand our project and how we should approach it, we had to first 
analyze our needs.  Based on our revised problem statement and meetings with our client, we 
developed a set of benchmarks that define the physical properties of a successful tissue tube.  
Table 4.1 displays our benchmarks and their respective target values.  After setting benchmarks 
for our designs, we reexamined our objectives and developed a list of specific functions that our 
design must perform.  
Table 4.1: Physical Benchmarks of Tissue Tubes 
Benchmark Target Value 
Tissue Tube Inner Diameter 0.5-4mm 
Tissue Tube Length 3-5cm 
Mechanical Integrity Able to be manipulated without falling apart 
 
Additionally, for each of our functions, we developed a list of means by which our design 
could achieve that function. These means, along with their respective functions were placed into 
functions-means trees. The functions-means trees are shown in Appendix B.  The functions we 
devised and how they relate to our design concepts will be discussed in further detail in later in 
this chapter. 
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4.2. Conceptual Designs 
Various methods were devised to seed cells effectively onto a tubular mandrel. Active 
methods include using centripetal force, gravity or a vacuum to force the cells to coat the 
mandrel. Passive methods include using materials with adhesive properties such as collagen, 
fetal bovine serum, or Poly-(N-isopropylacrylamide) (NIPAAM) to coat the mandrel. Some 
designs used a rotating mandrel in order to get the cells to coat the mandrel surfaces evenly. 
Many of our alternative designs, described below, incorporate more than one of these methods to 
seed the cells effectively and evenly onto the mandrel. 
The mandrel material was designed to promote adhesion of cells onto its surface while 
they grew into a tissue tube. Some designs required media to flow down the center and through 
the material. Using a hemocytometer, the size of the cells was estimated and most RSMCs were 
between 30 and 50 µm.  This requires that the mandrel material chosen contains pores smaller 
than 30 µm. This would ensure that media flows through the mandrel, but the majority of cells 
would remain on the outside. Finally, once the tissue tube grew around the mandrel, it would 
need to be detached from the mandrel in a relatively easy manner. This could be accomplished 
through use of a bioinert material or an exertion of force such as a pressure. Bioinert materials 
that could be used for the mandrel are listed below in Table 4.2.  
The bioreactor segment of the design was intended to automate the process of feeding the 
cell cultures while maintaining an optimal physiological environment. Many of these functions, 
such as maintaining temperature, oxygen, and CO2 levels, would be carried out by the incubator 
where the device would be placed. The main constraint of the bioreactor is that it would have to 
fit into the incubator. The bioreactor would also need to circulate nutrient media, keep 
contaminants out, and maintain pH and salt concentrations. This would be accomplished through 
the use of a peristaltic pump that would continuously circulate media through the culture 
chamber and a media reservoir. Additionally, the reservoir would be large enough to contain 
enough media to maintain salt and nutrient concentrations throughout the growth period. The pH 
of the media would be controlled through pH buffers and CO2. The media reservoir would be 
changed once the concentrations of salts and media became too low or if the concentration of 
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metabolic wastes became too high. This can be determined based on color changes within the 
media. 
Table 4.2: Possible bioinert mandrel materials 
Type of 
Material 
Material Options 
Polymer PTFE PEG Polystyrene Polysulfone UHMWPE Polypropylene 
Ceramic Alumina Zirconia Glass    
Metal 
Stainless 
Steel 
Co-Cr 
Alloy 
Ti-Al-V 
Alloy 
Gold   
4.3. Preliminary Designs 
After developing the various means for our designs, we combined our concepts for 
mandrels, cell seeding methods and bioreactors into several preliminary designs. Next, we 
created four preliminary designs that we chose to pursue as possible candidates for our final 
device. This section will outline each of our four preliminary designs including: advantages, 
limitations, and a detailed description of each design. 
4.3.1. Vacuum Design 
One of the bioreactor designs featured a porous inner mandrel material that utilizes a 
vacuum force for cell seeding. A schematic of the design is shown below in Figure 4-1. In this 
design, the mandrel is placed within the bioreactor chamber and immersed in a media and cell 
solution. A pump is used to drain the media from the inside of the mandrel where it is circulated 
and then returned through inlet tubes from the outside of the chamber.  Four inlet tubes are used 
to allow for attachment of a motor shaft to rotate the chamber. The size of the pores of the 
mandrel would be smaller than 30 µm. This would ensure that media can be drawn through the 
mandrel, while the cells remain stuck on the surface of the mandrel. A preliminary CAD drawing 
showing the major components is seen below in Figure 4-2. A series of inlet tubes feed media to 
the chamber, while media is drawn out from a tube that is connected to the inner portion of the 
mandrel, causing a vacuum force from outside to inside of the mandrel. Included with the 
chamber is a rotation motor that is used to disperse the cells in the media and evenly coat the 
surface of the mandrel. A media reservoir is used to contain the media as it circulates. A large 
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media reservoir ensures that the solution is buffered properly and contains enough nutrients to 
sustain the cells throughout the growth period. 
-
 
 
 
Figure 4-1 Porous Mandrel and Cell adhesion due to Vacuum 
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Figure 4-2: CAD drawing of vacuum design 
Advantages for this design include a simple mechanism for cell seeding. This design 
evenly coats mandrels because as cells stick to the surface of the mandrel and cover up pores, 
they would impede the vacuum force of the covered pores. This would result in the cells being 
forced to stick to the open pores, thereby coating the mandrel evenly. Once the cells have grown 
to confluency around the mandrel, they could be removed by reversing the pump, which would 
apply a pressure to force the tissue off of the mandrel surface. The shear stress from the vacuum 
could also be an advantage by mechanically stimulating the growing cells. However, the 
unknown shear stresses may be too strong and destroy the cells. Another disadvantage of this 
approach is the complexity of the design compared to the other designs. This would require 
many moving parts and would be harder to manufacture. 
4.3.2. Washing Machine Design 
Another approach to seeding cells onto a mandrel uses a rotating inner mandrel surrounded 
by a finned outer tube as seen in Figure 4-3. Cells are injected into the open area between the 
mandrel and outer tube. Similar systems have been developed by NASA to keep cells in constant 
freefall and create cellular aggregates.
31
 Based on this design’s appearance, we’ve named it the 
washing machine design. 
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Figure 4-3: Schematic of Washing Machine 
This design will have an inner mandrel composed of a material that allows cell adhesion. 
The material must be porous enough to allow fluid flow to the chamber and be bioinert.  A 
porous material is necessary to allow fluid flow through the lumen of the tissue tube in order to 
ensure adequate nutrient perfusion throughout the tube. To optimize this design we could control 
the rotational speed. As the vessel chamber is rotated, the cells are captured by the grooves in the 
fins and are carried to the top of the chamber where they naturally fall due to gravity. The cells 
then have a chance of sticking to the inner mandrel, which rotates the opposite direction to 
maximize even cell seeding of the inner mandrel. The design of the fins can be varied to 
optimize the number of cells that are directed towards the inner mandrel.   
There are a few advantages to this design: mechanical stresses on the cells are likely to be 
low due to the slow rotation rate, ensuring the cells’ safety in the bioreactor and the porous inner 
mandrel allows feeding inside the lumen of the tissue tube. The constant fluid motion also lends 
itself to even media and nutrient distribution. Additionally, this design is cost-effective and is 
relatively simple to manufacture.  
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4.3.3. Agitation Design 
This preliminary design takes advantage of gravity in order to seed cells onto one of many 
mandrels. The design consists of a box with one removable side as illustrated in Figure 4-5. 
There are numerous mandrels attached to the side of the box that is opposite from the removable 
side. On the removable side there are holes that correspond to each of the mandrels to provide 
support once the entire box is assembled.  The assembled box is shown in Figure 4-6.  Finally, 
there are injection sites at the top of the box, one is used to inject the cells into the device and the 
other allows for air that is originally in the device to exit when cells and media are injected. Both 
holes can be sealed using medical grade silicone glue. The device is injected with cells and 
media and then attached to the motor, which agitates the entire device allowing the cells to 
contact and adhere to any of the mandrels. The device is left in this position until most of the 
cells that have not attached have hit the bottom of the chamber. The device is then flipped 180 
degrees and the process is repeated in the opposite direction.  The seeding process is illustrated 
in Figure 4-4. 
 
Figure 4-4: Schematic of Agitation Design 
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 The main advantage of this device is that multiple tissue tubes can be made at once. 
Additionally, the unit is entirely self-contained, which is advantageous because once sterilized, 
the risk of contaminating the device is very low. 
 The major disadvantage of this design is that it relies on random freefall to seed cells onto 
mandrels. Other disadvantages include the precision needed for successful seeding and the 
wasted materials from unsuccessful seeding. The speed of both agitation and rotation must be 
carefully assessed to find optimal speeds for each motion. Finally, cells that either don’t adhere 
to a mandrel or adhere but do not completely form a tube around a mandrel will be wasted. More 
waste will occur because the size of this bioreactor is larger than other designs since it contains 
numerous mandrels, therefore more media will be required to fill the bioreactor and ensure that 
the cells are being adequately fed.  
  
Figure 4-5: The main box-like part of the agitation design is seen on the left and 
the cover to the box is seen on the right. Fifty individual mandrels are 
dispersed on the cover and fifty corresponding attaching pegs can be seen 
inside the box. 
  
36 
 
 
Figure 4-6: An exploded assembly of the entire agitation device. The box and 
the cover structure fit together and the mandrels and their corresponding 
pegs align and connect. 
4.3.4. Teacup Design 
 Another of our preliminary designs, which we called ―the teacup‖, takes an entirely 
different approach to cell seeding in comparison to our other designs. In this design, illustrated in 
Figure 4-7, we attempt to seed the cells on the inner surface of a glass tube rather than the outer 
surface of a mandrel. This design provides a unique advantage in that simply rotating the 
mandrel at a slow rate will allow the cells to settle on the seeding surface due to the force of 
gravity. There are four major components necessary for this design: the outer seeding mandrel, 
the inner mandrel, the mandrel supports, and the bioreactor/rotation mechanism. 
The initial concept for this design used a thin coating of the thermo-responsive polymer 
NIPAAM on the inner surface to allow for cell attachment. NIPAAM is a hydrogel that exhibits 
phase separation when lowered below its lower critical solution temperature of 32
o
C. Below the 
LCST, NIPAAM exists as hydrophilic coils of single chains. Above the LCST, NIPAAM 
undergoes a sharp coil-to-globule transition and as a result forms into a hydrophobic aggregation. 
This polymer coating can then be released by lowering the system to below its LCST, thus 
detaching the cell tube from the outer mandrel. If correctly constructed, this system would make 
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the removal of the cell tube from the mandrel easy and efficient. The outer mandrel will likely be 
composed of either plastic or Pyrex glass that can be easily coated with NIPAAM. 
The inner mandrel of the teacup design concept functions mainly to ―catch‖ the tissue tube 
once it has been released from the outer mandrel and to prevent the tissue tube from closing once 
it has been released. The initial design called for the inner mandrel to be composed of a porous 
material that would prevent cellular ingrowth but allow for fluid flow through the lumen of the 
tissue tube. As our studies progressed, however, we have realized that by supplying fluid through 
the tube at low physiological pressures (80mmHg), we should be able to keep the tissue tube 
open without using an inner mandrel. Another possible replacement or change to the inner 
mandrel design is the use of a thin fiber in place of the mandrel that will simply act as a deterrent 
to the tissue tube closing in addition to the fluid pressure. 
 
Figure 4-7: Schematic of Teacup Design utilizing rotation for even cell seeding 
of inner vessel surface 
The mandrel supports, shown as a close-up in Figure 4-9, in the teacup design will need to 
perform several different functions. First and foremost, these supports must seal the outer 
mandrel from the outside environment and prevent transmittance of bacteria or other infectious 
agents into the bioreactor system. Second, the supports must easily connect to the bioreactor 
system and allow for fluid flow into and out of the polymer tube. Third, the outer mandrel 
supports must interface with a gear or pulley system on one end of the mandrel to allow for the 
continuous and slow rotation of the mandrel. Finally, the mandrel supports must have a built in 
mechanism for ―catching‖ the open ends of the tissue tube once it has been released. In our first 
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design for this concept, this catching method is composed simply of hook-like protrusions which 
will capture the cell sheet as it is released from the outer mandrel. 
Figure 4-8 shows a solid model of the entire teacup preliminary design.  The inner and 
outer mandrels are held in place by the mandrel supports and one of the mandrel supports 
includes a gear to allow for rotation of the entire mandrel system.  Both the inlet and outlet of the 
design will be connected to a peristaltic pump using a syringe. Figure 4-9 shows a close-up of 
one of the two mandrel supports for the ―teacup‖ design.  The important entities shown in Figure 
4-9 are the clear glass outer mandrel, the inner mandrel, the geared mandrel support and the 
syringe tip.  Also of significant importance are the smooth hooked protrusions on the tip of the 
mandrel supports.  These protrusions are designed to ―catch‖ the tissue tube when it is released 
from the outer mandrel.  
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Figure 4-8: Solid model of the "teacup" design.  This design will interface with a 
fluid flow bioreactor using two standard 18 gauge syringes (only one is 
pictured) and includes both an inner and outer mandrel which are held in 
place by two mandrel supports.  One mandrel support allows the model to 
be geared to a motor. 
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Figure 4-9: Close-up view of a mandrel support. 
Compared to our other designs, the teacup design has several key features that make it 
attractive. First and foremost, since it seeds the cells on the inside of a mandrel, the teacup design 
does not require an inner mandrel that is either porous or promotes cell seeding. This solves the 
major issue of finding and testing mandrel materials that meet strict design criteria. Second, 
based on our preliminary experiments, the teacup design may be possible to use without the use 
of NIPAAM or other coatings.  This eliminates the need to develop a method of coating mandrel 
surfaces. 
The teacup design concept includes several assumptions that must be proven before it can 
be considered a viable design. The first assumption is that we can form a NIPAAM polymer 
coating on the inner aspect of a glass or polymer tube. To our knowledge, this has not been done 
in any scientific literature to date. This has, however, been successfully accomplished on the 
outer aspect of glass tubes.
32
  Based on our preliminary experiments, we may eliminate this 
assumption. The second assumption is that the cells will contract when released from the outer 
mandrel and remain a contiguous tissue tube. Based on our preliminary experiments thus far, we 
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have found that smooth muscle cells that are grown on tissue culture plates will spontaneously 
release in a tissue sheet when they reach a certain cell density. As such, we believe it is 
reasonable to expect that a similar phenomenon will occur when the cells are released from a 
NIPAAM coated tube and possibly from a tube without a NIPAAM coating.  
Despite its promise, the teacup design does present with several limitations. First and 
foremost, the teacup design does not provide an easy method for increasing production of blood 
vessels. Since the design is such that a single blood vessel is made in its own self contained 
environment, manufacturing of multiple blood vessels simultaneously would require that a new 
self contained vessel reactor to be built for each additional vessel.  
4.4. Feasibility Study 
An evaluation matrix was generated to distinguish advantages and disadvantages between 
each alternative design. The scores were based on data from the conceptual testing regarding 
how well each design suits the necessary functions as described by our constraints and 
objectives.  Each score was given out of 100 by the design team. The final scores were based on 
our objective weights from the pair wise comparison charts in Appendix A. 
.  The final ratings are expressed as a percentage. These objectives have also been given 
weights correlating to their significance for a successful overall design. Designs were evaluated 
for individual performance, then scaled based on importance of each function and for each sub-
objective, unless the design must be ruled out due to lack of compliance with constraints.  
The constraints specified that the resulting bioreactor must meet several conditions. It must 
be composed of biocompatible materials, easy to sterilize, allow for safe removal of a completed 
tube, allow for seeding of SMCs, and be sized to fit into an incubator. As each design operates 
within these constraints, analysis is next governed by a design’s ability to complete device 
objectives. Major objectives were subdivided to provide sufficient discriminatory detail among 
designs. The major objectives, by order of decreasing weight were mandrel support functions, 
cell-seeding functions, and bioreactor functions. 
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Table 4.3: Conceptual Design evaluation matrix 
OBJECTIVE 
OBJECTIVE 
WEIGHT 
SUBOBJECTIVE 
SUBOBJECTIVE 
WEIGHT 
Teacup 
Vacuum 
Design 
Pinball 
Washing 
Machine 
MANDREL 
2 
Cells adhere to 
mandrel 
2 85 80 60 75 
 
TEBV easily 
removed 
3 100 100 85 100 
 Totals: 0.94 0.92 0.75 0.9 
CELL 
SEEDING 
3 
Cells adhere 
uniformly 
2 95 85 70 90 
 
High Success 
seeding rate 
1 95 95 95 90 
 
Grow and support 
own ECM 
3 100 90 100 85 
Totals: 0.975 0.892 0.8917 0.875 
BIOREACTOR 
1 
Media 
Circulation 
3 100 85 90 100 
 
Maintain 
physiological 
environment 
2 100 100 100 100 
Totals: 1 0.91 0.94 1 
 Overall Total: 96.8% 90.4% 85.3% 90.4% 
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5.0 Design Verification 
As mentioned in the previous chapter, four preliminary designs were created to achieve 
the necessary goals and objectives as dictated by the client statement. Each design took different 
approaches to the same goal of ultimately growing a tissue tube. This chapter describes in detail 
the preliminary tests and results for each conceptual design. The specific testing protocols can be 
found in Appendix C. 
5.1.  Vacuum Design 
 The vacuum design featured a porous inner mandrel and utilized a pump to create a 
negative pressure within the mandrel, which would seed cells onto its outer surface. To test this 
concept, two mandrel types were created from different materials.  
The first experiment used nylon mesh which contained 34 µm pores. It was estimated 
through a hemocytometer that the size of a rat aortic smooth muscle cell (RSMC) is between 
30µm and 50µm. Therefore the pore size was small enough to capture the RSMCs. The nylon 
mesh was fixed into a conical shape and glued using medical grade silicon as shown in Figure 
5-1. 
 
Figure 5-1: Nylon Mesh configured into a conical shape 
The wider ends of the nylon cones were plugged with Polydimethylsiloxane (PDMS). 
These cones were placed in a cell solution containing 90% Dulbecco’s Modified Eagle Medium 
(DMEM), 10% Fetal Bovine Serum (FBS) and 1% of the antibiotic combination 
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penicillin/streptomycin. Vacuum forces were created by using a micropipette with a 1mL tip 
which would theoretically pull cells and force them to adhere to the outer surface of the nylon 
cones.  It was found that this approach was an ineffective method for producing vacuum forces 
as the micropipette tips did not form a strong seal with the ends of the nylon cones. The first of 
the nylon cones was sacrificed at day 3, and another was sacrificed every day afterwards. It was 
found that no cells were able to adhere and grow onto the nylon cones as shown below in Figure 
5-2 (left). This image is shown in comparison to Figure 5-2 (right) which is a control nylon cone 
that did not undergo cell seeding.  
 
Figure 5-2: Nylon Mesh under a 10X Optical Microscope after cell seeding  
using vacuum forces(left) and without being seeded (right) 
The second experiment for the vacuum design used polysulfone as a mandrel material as 
shown below in Figure 5-3. The polysulfone mandrel was clamped down on one end, and a 
needle and syringe were used to create a vacuum. Solution media was aspirated through the 
middle of the mandrel. It was found that creating a vacuum through the polysulfone mandrel was 
difficult and the needle easily pierced through the mandrel. The mandrel material could not be 
viewed under a microscope due to its thickness, and trypan blue staining yielded inconclusive 
results as the material absorbed the dye. However, after 14 days, the nutrient medium remained 
the same color suggesting no metabolic activity of any kind and therefore it was unlikely that 
cells were present.  
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Figure 5-3: Photograph of Polysulfone Mandrel in Nutrient Medium 
These preliminary experiments suggest that the available materials would not work 
effectively with this design. Furthermore, suitable manufactured porous mandrels could not be 
found for purchase, and manufacturing the mandrels in-house was not feasible due to time 
constraints, equipment, and expertise required.  
5.2. Washing Machine Design 
The washing machine design took advantage of convective motion to direct cells towards 
an inner mandrel. Testing of this model involved anticipating fluid pressures and velocities to 
predict the particle path within the vessel.  This testing was best achieved by using computational 
fluid dynamics and several models were created and testing using the FLUENT fluid modeling 
program. The various parameters of the models including fin shapes, sizes, and vessel rotational 
speeds are described in Appendix C.  
Figure 5-4 is a graphical representation of fluid velocity and direction in one of the 
washing machine vessel options. At a rotation speed of 2.0 rad/s, the fluid velocities in m/s can 
be seen in the right hand side of the diagram.  
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Figure 5-4: FLUENT Model of a concave fin Washing Machine Design 
 It can clearly be seen that the majority of the fluid is directed towards the outer portions of 
the vessel due to the centripetal force from rotation. This would cause cells to congregate in 
pockets near the fins.  If rotational speed is decreased, gravity overcomes the rotation and the 
cells aggregate at the bottom of the chamber.  If the rotational speed is increased, the centripetal 
forces hold the cells on the outer surface and do not allow them to drop on the mandrel.   As a 
result, the washing machine design would not have efficient cell seeding of the inner mandrel 
due to the majority of cells aggregating on the outer fins. 
5.3. Agitation Design 
This preliminary design takes advantage of gravity in order to seed cells onto one of 
many mandrels. To conceptually test this design, a model was built using a Petri dish for the 
vessel, silicone tubing for the mandrels, and pepper to represent cells. A photograph of the model 
can be seen below in Figure 5-5. By rotating the model, the interactions between the pepper 
particles (cells) and silicone mandrels could be visualized. It was found that the rotation caused a 
―snow globe‖ effect, and the pepper particles were able to evenly ―coat‖ the mandrels. 
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Figure 5-5: Model of Agitation design with Pepper Particles to visualize fluid 
flow 
Due to the successful results of even coating of the conceptual agitation design model, a 
prototype of the agitation design was built and tested with actual RSMCs. The prototype was 
similar to the model, but in this case, the silicone mandrels were coated with fetal bovine serum 
(FBS) in order to adhere to the cells. This was achieved by soaking the mandrels overnight at 
25
°
C and allowing it to dry; thereby creating a coating of adhesive proteins on the silicone 
mandrels. A cell solution containing approximately 20 million cells was injected into the vessel 
and cultured for 5 days. After the fifth day, the prototype was fixed with 70% ethanol, and 
stained with trypan blue. A photograph of the stained prototype is shown below in Figure 5-6. 
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Figure 5-6: Agitation Prototype Stained with Trypan Blue 
The stained prototype shows uneven adhesion of the cells onto the mandrels. The bottom 
portion of the mandrels received an even coating of cells, however, there was little to no 
adhesion of cells on the top half. In addition, a large amount of cells adhered to the vessel wall 
itself. Due to these results, this design was not pursued further. 
5.4. Teacup Design 
In this conceptual design, Rat Aortic Smooth Muscle Cells (RSMCs) are seeded onto the 
inner surface of a glass tube rather than the outer portion. The glass tubes were scored and 
snapped using a triangular file and the ends were plugged using PDMS. The PDMS plugs had to 
be cured in an oven at 60
O
C for approximately 1 hour.  A cell solution was then injected using 
sterile syringes and 20 gauge needles. It was found that a cell seeding density of 250,000 cells 
per tube achieved the best coverage. The tubes were marked evenly into eight sections 
circumferentially, and were rotated 1/8
th
 of a turn every 10 minutes for 2 hours after the initial 
cell seeding. The cells were then fed with 3.0 mL of fresh DMEM every day until they were 
ready for harvest. It was found that leaving the needle tips in the PDMS plugs with filtered 
micropipette tips plugging the syringes allowed for sufficient gas exchange. 
 Due to the curvature of the tube it was difficult to view the tubes under a microscope. 
Cell adhesion was determined by fixing the cells in 70% ethanol and staining with Trypan Blue. 
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A picture of a stained tube and a control tube is shown below in Figure 5-7. It can be seen that 
there is generally uniform coverage around the inner diameter of the tube. However, there are 
some areas with little cell adhesion. The unstained region near the top of the tube is most likely 
due to the feeding process. Injecting fresh media through a 20 gauge syringe most likely sheared 
off cells in that region. In addition, small air bubbles found in the tubes would kill cells near the 
center after a prolonged amount of time. These problems could potentially be resolved through 
the use of an automated feeding system using a pump and a reservoir.  
 
Figure 5-7: Teacup tube stained with trypan blue (left) in comparison to 
unseeded tube (right). 
5.4.1. Tissue Contraction Tests 
 Once the cells were seeded onto the tubes of the teacup design, a procedure is required to 
remove the tissue sheet from the tubes. Earlier experiences with tissue culture found that RSMCs 
would contract off tissue culture dishes spontaneously if they are 100% confluent after a 
complete media change. It was thought that this contraction could be used to harvest completely 
formed tissue sheets from the inner diameter of tubes. Once contracted, they can be captured and 
continually cultured for proper mechanical strength and tissue tube thickness.  
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 To take advantage of the contractile properties of the cell as described above, other 
methods for forcing cell contraction were researched. It was found that the tissue sheets can be 
forced to contract at will by completely replacing the medium with 60 mM Potassium Phosphate 
Saline Solution (K-PSS) at 37
o
C.  A conceptual picture describing the steps of inducing tissue 
contracting using K-PSS is shown in Figure 5-8. The tissue sheet will then contract within 2 
hours. The requirements of this procedure are that the cells must be nearly 100% confluent and 
must have enough contractile proteins in their extra cellular matrix. This can be achieved by 
seeding the cells at a low density and allowing them to grow for a sufficient amount of time to 
produce contractile proteins. Figure 5-9 shows a tissue sheet that has contracted into an inner 
mandrel.  
 
Figure 5-8: Conceptual representation of K-PSS contraction off of a glass tube 
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Figure 5-9: Tissue Sheet Contracted Around Inner Mandrel. Yellow media 
indicates an acidic pH. 
 As shown by the preliminary test results for the Teacup design, uniform cell adhesion to 
the inner diameter of glass tubes can be achieved. It was determined that the tissue can be 
harvested using K-PSS by contracting the tissue onto an inner mandrel. Once the tissue has been 
harvested, it can continue to be grown until the cylindrical tissue has sufficient mechanical 
properties for testing.  Due to these successes, we chose to purse the Teacup design as our final 
design. 
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6.0 Discussion 
The following section will summarize and evaluate the major implications of our 
preliminary testing. This testing was used in order to select a final design to further pursue. 
6.1. Vacuum 
The first preliminary tests of the vacuum design showed that cells were unable to adhere to 
the nylon mesh as was intended. Although the size of the pores was chosen to be less than the 
diameter of the RSMCs, cells were still unable to adhere to the outside of the mesh mandrel.  
This may be due to the viscoelastic properties of cells, as their ability to deform may have 
allowed them to slip through the pores of the mandrel.  Although smaller-sized mesh material 
could be purchased or manufactured, these materials would add greatly to manufacturing costs or 
would otherwise require knowledge of the limit to which cells may pass through an opening, 
which may require further testing. It was assumed that the cells would behave as solids, but 
because they passed through a mesh that was smaller than their diameter, they clearly must be 
capable of deforming in response to pressures.  
Additional testing, involving the use of polysulfone tubing yielded different testing results. 
Polysulfone was used as a mandrel in previous MQPs
33
 and is both porous and elastic, conducive 
to media circulation, gas exchange and vessel removal. However, for the purposes of this project, 
the tubes were ineffective at seeding cells without using an adhesive coating. The smaller pores 
of the polysulfone tubing seemed small enough to block the cells from entering the mandrel, but 
would still allow for media circulation to the surrounding cells.  Unfortunately, the small size of 
the pores made the pressure too high to effectively seed the mandrel with cells. These are not the 
convenient cell seeding conditions that the group intended to achieve. Additionally, the 
polysulfone absorbed the trypan blue dye, leaving cell staining tests inconclusive. It appeared 
that the material simply absorbed the dye, although it is possible that all of the cells stained were 
localized within the mandrel.  In case of complete cell absorption, the tubes were allowed to 
culture for an additional two weeks, but judging by media color as an indication of nutrient 
depletion, there was little to no metabolic activity. Therefore this process was deemed ineffective 
at supporting cells for tissue culture.  
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Both tests proved that this design, as tested with the available materials and within project 
constraints, is incompatible with the objectives for both the mandrel and cell seeding which 
assert that cells must stick to the mandrel without integrating with it.  
6.2. Washing Machine 
Testing of the washing machine effectively demonstrated that the design would not be the 
optimal for this project’s purposes. Velocity vectors visualized using FLUENT, a computational 
fluid dynamics analysis program, indicated that particles would be directed along the outer wall 
of the vessel.  This result was directly opposite of the goal to force cells on the mandrel. Multiple 
fin-mandrel configurations were tested including convex waves, concave waves, and a control 
model of concentric cylinders rotating at the same angular velocity.  However, none of these 
models yielded desirable results.  
Accurately modeling the washing machine system was limited by the user’s ability to 
describe the environment in terms that the program could compute. Although several values and 
options were explored, simulations showed results that could not be interpreted when attempting 
to use the Macroscopic Particle Model, (MPM).  Due to its predicted insufficient ability to 
successfully seed cells uniformly onto the mandrel, this design was abandoned as ineffective and 
other designs were pursued.  
6.3. Agitation 
The successful initial testing of the agitation method made it a strong candidate for the 
final design. The initial testing of the agitation model using pepper to represent cells showed that 
the probability of cells adhering to each mandrel in the model was promising enough to follow 
through with an experiment using live cells. The design required only seeding of cells and a 
single manual 180 degree rotation of the housing structure making it simple to use and requiring 
only a short amount of time to operate. It satisfied all of the team’s objectives for a mandrel 
which cells could adhere to, as well as for uniform cell seeding and maintaining a 
physiologically favorable environment for cells. These results encouraged the group to further 
explore this design’s capabilities with live cells.  
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The second phase of testing confirmed that the agitation method was a viable design for a 
vascular graft bioreactor.  Using a similar Petri dish setup with FBS-coated silicone tubes, live 
cells were seeded into the agitation prototype.  The prototype was rotated 180 degrees every half 
hour for two hours.  It was then allowed to culture for five days. The results showed consistent 
coating patterns on all mandrels.  The individual mandrels were not, however, coated evenly.  
Trypan staining of cells showed that seeding of each individual mandrel was only about 50% 
successful, as cells adhered almost exclusively to the lower half of the mandrel, likely due to the 
force of gravity.  
The effective seeding of cells onto multiple mandrels and its capabilities for media 
circulation made it a highly attractive improvement to the current challenges of cell seeding.  
Unfortunately this design was also ultimately ruled out due to the low success rate of cell 
seeding, and also because it was limited by its ease of manufacture. Although having 50 
mandrels in one design greatly increases its rate of tube production, manually configuring each 
device took far too long and greatly decreased the ease of operation for the user, which takes 
precedence over the number of vessels produced.   
6.4. Teacup 
The unique concept of seeding cells onto the inside of a tube proved to be the innovation 
that propelled the project towards pursuing this design. Seeding the cells onto the inner tube 
essentially creates a continuous surface upon which cells may accumulate and form adhesions to 
one another. In this way, the vessels may be devoid of seams that can be produced by seeding 
cells onto different parts of the mandrel at different times and can leave tissue susceptible to 
mechanical failure.  By taking advantage of gravity to direct cells towards the bottom of a 
cylindrical tube, and simply rotating the tube, cells will contact the wall of the tube at every point 
and are far more likely to form a vessel of uniform wall thickness. Determining the optimal cell 
concentration and frequency of tube rotation would provide sufficient information to produce 
tissue tubes.   Ultimately these conceptual experiments show that this design concept could 
potentially meet our design objectives as set forth in Chapter 3.  
The method of removal devised solidified the teacup’s place as the conceptual design to 
pursue as a prototype. Taking advantage of the contractile nature of RSMCs allowed the tissue 
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tube to be contracted onto the mandrel by administering K-PSS and returning the vessel to an 
incubator for 30 minutes. This method of removal lessens the risk of tearing the tissue as 
compared with manual removal. 
The teacup design satisfied all of the defined objectives for cell seeding, physiologically 
supporting cells, and the mandrel-tissue interactions. There were adequate success rates for cell 
seeding and uniformity, no need for adhesive or any artificial matrix, and the cells remained 
viable throughout the culture process. The mandrel was designed to provide structural support to 
the tube once contracted, while not interacting with cells or hindering tube removal in any way. 
The design effectively circulates media and uniformly distributes cells to form a confluent, 
continuous sheet. All materials chosen were biocompatible and easily sterilized, and the 
assembly is fit for use in an incubator.  
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7.0 Final Design and Validation 
 Based on the testing and validation of the four conceptual designs, we were able to 
develop the design that held the most promise and to apply our time and effort to improving the 
design. During preliminary testing, the teacup design showed the most promise, therefore, the 
final design uses many of the features seen in the teacup design.  Despite this, several aspects 
from other conceptual designs were incorporated into the final design.  In this chapter we will 
first describe the different parts used to build the final prototype, and then discuss the methods 
we used to construct and test the design with cells, and finally, we will discuss the methods we 
used to verify that our final design meets the design objectives set forth at the beginning of the 
design process. 
7.1. Part Acquisition and Modification 
 In order to build our final design within our time and budget constraints, acquiring 
materials from various sources was necessary.  After acquisition, these materials were modified 
to meet the specific design specifications of each aspect of our project. 
7.1.1. Octagonal Stand 
 The only custom part that was built specifically for our final design is the octagonal 
stand.  The stand, shown in Figure 7-1, was designed in Solidworks and manufactured out of 
Acrylonitrile Butadiene Styrene (ABS) plastic using rapid prototyping.  Two stands are needed 
in order to seed and grow eight tubes.  The primary function of the stand is to hold the glass cell 
seeding tubes and the steel inner mandrels in place throughout cell seeding.  The large 
indentation seen in Figure 7-1 inset is designed to hold the glass seeding tubes while the hole 
centered in the indentation is designed to hold the inner mandrel.  This design allows for both 
mandrels to be held firmly in place throughout cell seeding.  The additional off-center holes in 
the indentations are designed to allow 20 gauge syringe access to the tubes for easy cell seeding 
and media exchange.  The octagonal shape of the tube holder is designed to allow for metered 
manual rotation.  This shape allows the stands to hold the tubes in eight different positions with 
respect to gravity, allowing for even coating of cells on the glass tubes.  This process is shown 
schematically in Figure 7-2.  The square central hole in the stands was designed to allow the 
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stands to interface with and be rotated by a rotisserie system, which allows for the automatic 
rotation during the cell seeding process.  We used the manual seeding process during our earlier 
tests before we were able to build an automatic rotation system.   
 
Figure 7-1: Octagonal stand.  This part can be used to hold up to 8 mandrels 
and cell culture tubes.  This design allows for seeding of multiple tubes in 
limited space.  The inset shows an indent designed to hold a glass cell 
seeding tube, a centered hole to support an inner mandrel and a hole for 
cell injection and media flow. 
 
Figure 7-2: Schematic showing the manual rotation of the octagonal stand  
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7.1.2. Cell Seeding Tube 
The functional component of the cell seeding aspect of our design is the Pyrex glass tube.  
These tubes were derived from standard 5mL Pyrex glass pipettes.  The pipette tips are scored 
every 9cm using a triangular file and snapped by hand.  A solid model of one of these tubes is 
shown in Figure 7-3.   The tubes are secured to the octagonal stand using PDMS.  The octagonal 
stand also serves as a mold for the PDMS ensuring that the inner lumen of the tubes is sealed 
from the outside environment. 
 
7.1.3. Inner Mandrel 
 The inner mandrel was included in our final design to ―catch‖ tissue tubes after they 
contracted off of the cell seeding tube.  The inner mandrels are derived from a small stainless 
steel tube that was scored and broken by hand to span the distance between the two tube holders.  
The inner mandrel is shown in Figure 7-3 in the middle of the cell seeding tube. The inner 
mandrels are secured to the tube holding stand using PDMS. 
 
Figure 7-3: Solid model showing the inner mandrel and cell seeding tube 
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7.1.4. Automated rotation device 
 An automated rotation system was built to increase the uniformity of cell seeding and 
decrease the amount of operator time and effort.  A Mr. Flame™ rotisserie was purchased from 
Son of Hibachi™ and incorporated to rotate the entire tube cartridge system.  The Mr. Flame 
rotisserie is firmly attached to a metal base such that there is enough clearance under the 
rotisserie bar to support the tube cartridge.  The final automated rotation system is shown below 
in Figure 7-4.  Since the original rotation rate of the rotisserie was about 6 rotations per minute,  
a Vex gearing system was used to reduce the rotation rate of the cartridge to the experimentally 
determined rate of one rotation per hour.  This system, constructed of three pairs of gears with 
7:1 gear ratios, provides a total ratio of 343:1.  This ratio converts the average rotation rate of the 
cartridge to about one rotation every 55 minutes. The seeding cartridge is designed to slide 
directly onto a removable axle, making attachment or removal of the cartridge quick and easy. 
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Figure 7-4: Automated rotation system of the tube stands using a rotisserie 
motor. This setup rotates the stand approximately one turn every hour. 
7.1.5. Peristaltic pump 
 A low flow peristaltic pump was acquired from the Rolle Lab to provide fluid flow to all 
of the tissue tubes.  A peristaltic pump was optimal for our application because we need to keep 
the inside of our tubing sterile to prevent contamination of our cells.  A low flow pump was 
chosen to prevent shearing of cells off of the walls of the tubes.  The peristaltic pump used for 
our design is shown in Figure 7-5. 
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Figure 7-5: The peristaltic pump used for fluid flow.  This pump is designed to 
pump sterile media without contamination. 
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7.1.6. Media reservoir 
 A media reservoir was built from a Pyrex bottle and two 1mL glass pipettes.  These 
materials were chosen because they are easily sterilized and attached to our tubing system.  The 
completed media reservoir is shown in Figure 7-6. 
 
Figure 7-6: The media reservoir that was used for our final design.  Two holes 
were made in the cap of this reservoir to allow for connection to the fluid 
flow system. 
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7.1.7. Gas exchange coil 
 A coil of silicone tubing was attached to the tubing system to increase the overall surface 
area of media exposed to silicone.  Since silicone allows is gas permeable, this created gas 
exchange for our media.  The gas exchange coil is shown in Figure 7-7. 
 
Figure 7-7- A gas exchange coil made from silicone tubing to provide gas 
exchange to our media.  The coil is about 50 inches long. 
7.2. Design assembly 
 Our final design assembly can be divided into two separate design components. The first 
component is the blood vessel growth cartridge.  This component is responsible for providing the 
necessary environment for cell growth and tube formation.  The second component is the media 
exchange system.  The media exchange system is responsible for supplying fresh media and 
effective gas exchange to all vessels throughout growth of the cell tubes.  The media system also 
contains the capability to inject K-PSS or other liquids directly into the cell tubes to cause tube 
contraction. 
7.2.1. Vessel growth cartridge 
 The vessel growth cartridge is built from two octagonal stands, eight cell seeding tubes 
and eight inner mandrels.  During construction, the back of the two tube holders are first covered 
with duct tape to block the feeding and mandrel holes and prevent leakage.  One octagonal stand 
is then placed on its back and eight inner mandrels and eight cell seeding tubes are then inserted 
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into their respective holes in the tube holder.  Polydimethylsiloxane (PDMS), an easily used and 
relatively cheap rubber polymer is then used to seal the tubes in place.  PDMS is mixed and 
poured in and around each cell seeding tube and mandrel.  The tube holder is then heated at 
approximately 60°C for one hour to cure the PDMS.  The second tube holder is then placed on 
its back on a table and the free ends of the mandrels and tubes are placed in the second tube 
holder.  PDMS is once again poured around the tubes to form a seal.  The PDMS is cured at 
60°C for approximately 1 hour.  The final result of this process is a seeding apparatus that can 
hold up to eight tissue tubes throughout the process of cell seeding and tissue growth.  The entire 
system can be autoclaved before use to ensure sterility.  A graphical depiction of the construction 
of the vessel growth cartridge is shown in Figure 7-9 and a picture of the actual constructed 
cartridge is shown in Figure 7-8 
 
Figure 7-8: The completed vessel growth cartridge. 
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Figure 7-9: Construction of the vessel growth cartridge.  (A) Duct tape is 
applied to the back of a tube holder and it is placed face up on a lab bench. 
(B) The glass cell seeding tubes and inner mandrels are placed in their 
respective holes in the tube holder.  PDMS is prepared and poured around 
the tubes and the PDMS is cured. (C) The second tube holder is seeded and 
placed face up on the bench top.  The free ends of the tubes are placed in 
the second mandrel and sealed with PDMS. (D) The final vessel growth 
cartridge is ready to be autoclaved. 
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7.2.2. Media exchange system 
 The media exchange system is composed of a media reservoir, a gas exchange coil, a 
peristaltic pump, 16 twenty gauge needles, a variety of luer-lock tubing accessories and a length 
of 1/8 inch silicone tubing.  The entire tubing portion and media reservoir of the media exchange 
system can be autoclaved before use to ensure sterility.  The final media exchange system is 
shown and described in detail in Figure 7-10. 
 
Figure 7-10: Media exchange system. Media is pumped from the media 
reservoir and through the gas exchange coil where it reaches each of the 
glass vessel culture chambers. From the culture chambers the media is 
returned to the reservoir for recirculation. Included in the tubing are ports 
where K-PSS solution can be injected into the media tubing system. 
7.3. Growth of tissue tubes 
 In order to maximize the efficiency and efficacy of our final design, we endeavored to 
reduce the number of steps involved in seeding and feeding the tubes while minimizing material 
expenditure and maintaining a sterile cellular environment.  As a result, the steps involved in 
using our design can be broadly divided into three major steps.  The first of these steps is cell 
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seeding, in which the goal is to evenly coat the glass tubes with cells at an ideal seeding density.  
The second of these steps is the growth phase during which we aim to provide optimum 
physiological conditions to the growing tubes.  The final step is the tube contraction step.  
During tube contraction, we aim to force the confluent tissue tubes to contract off of the seeding 
tubes and close around the inner mandrel.  During this period, we minimize the period of time 
that the cells are placed in a purely K-PSS solution. 
7.3.1. Cell Seeding 
 All of the steps in this method were completed under sterile conditions in a laminar flow 
hood. To begin cell seeding, we first spun down and counted rat aortic smooth muscles from our 
cell culture flasks.  We then diluted the cells to a target value and thoroughly mixed the cells in a 
conical tube.  A sterile 20 gauge needle was placed into the needle port of one of the cell seeding 
tubes in the sterile vessel growth cartridge.  While holding the cartridge vertically, with the 
aforementioned needle at the top, a volume of cell solution containing the target number of cells 
was slowly injected into the opposite end of the tube using a second 20 gauge needle and 3.0 mL 
syringe.  Next, approximately 1.5 mL of sterile media was injected in the same manner into the 
tube until media began to flow out of the upper needle.  Both needles were then carefully 
removed to minimize the formation of bubbles in the seeding tube.  These steps were then 
repeated for the remaining seven seeding tubes.   The seeding process is shown schematically in 
Figure 7-11. 
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Figure 7-11: Schematic showing the seeding of a Pyrex Tube.  This process is 
repeated for each of the eight tubes 
7.3.2. Tissue Growth Phase 
 After the cells are seeded on the glass tubes, it will be necessary to provide constant 
media and gas exchange to optimize cellular growth.  To accomplish this, we will attach the 
vessel growth cartridge to the media exchange system.  To ensure sterility, the entire system and 
tubing ends will be placed in a sterile laminar flow hood to make the connections.  A sterile 
60mL syringe will be used to inject media into the tubing upstream of the peristaltic pump in 
order to prime the pump and remove any potential air bubbles.  Sterile 20 gauge needles will be 
inserted into each of the 16 needle ports on the vessel growth cartridge.  The syringes will then 
be attached to the pump system as shown above in Figure 7-10.  Once the entire tubing system is 
sterilely connected, the entire apparatus will be placed in the incubator and fluid slowly pumped 
through the system. 
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7.3.3. Tube Contraction 
 The third and final step was to contract the cultured tissue from the seeding tubes.  After 
72 hours, K-PSS was drawn into a 25mL syringe and injected into the seeding tubes.  The tubes 
were left in the incubator and monitored until they had visibly detached from the seeding tubes 
and contracted around the inner mandrel.  This process typically took less than 20 minutes.  The 
tubes were then ready for removal or continued growth.  The contraction process is shown in 
Figure 7-12. 
 
Figure 7-12: After the cell seeding phase, the media is removed from the tube 
and replaced with K-PSS to induce contraction. 
7.4. Design Verification 
 The overall goal of our design was to create a viable tissue tube from completely cellular 
components using minimal operator time and resources.  To verify that our design achieved this 
goal, we tested several components of our design separately to show that our design will work in 
its intended manner.  The major parts of our design verification were to show that we could 
evenly coat a seeding tube with smooth muscle cells, to show that we could cause the smooth 
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muscle cells to spontaneously contract off of their substrate and to show that our bioreactor could 
provide even media flow to all eight tubes that were connected to it.   This section will describe 
the methods and results of our design verification experiments 
7.4.1. Even cell coatings 
 To test even coating of cells on the Pyrex glass seeding tubes, cells were manually 
injected into four sealed tubes and manually rotated by 1/8 of a rotation every 10 minutes for 2 
hours.  Two of these tubes were fixed with ethanol after 24hrs and two were fixed with ethanol 
after 72 hours.  The cells were stained with nuclear fusion red, which stains the nuclei of the cells 
a reddish color. This was accomplished by immersing the tissue in nuclear fusion red for five 
minutes and rinsing with distilled water. The distilled water was aspirated and replaced with 
ethanol for long term storage.  
 
Figure 7-13: Images showing confluency of cell seeding at 24 and 72 hours.  
The top three panels show different portions of a tube 24 hours after cell 
seeding.  The bottom three images show tubes imaged 72 hours after cell 
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seeding.  These images are representative of all sections of tubes.  Scale 
bars are 500 μm. 
7.4.2. Cell contraction 
 During our preliminary testing, we found that sheets of smooth muscle could be induced 
to contract off of tissue culture plastic using K-PSS.  In order to optimize this process, we used 
75 cm
2
 flasks and seeded them at either high cell density (16 million cells) or low cell density (2 
million cells) for 1, 2, 3 or 4 days.  During the cell growth period, we replaced the media as 
needed.  At the end of the growth period, we replaced the media with K-PSS and observed to see 
if the cell sheets contracted off of the plates.  Through these experiments, we determined that the 
optimal density was 2 million cells / 75cm
2 
with the addition of K-PSS after 72 hours.  This 
resulted in the contraction of essentially the entire sheet off of the tissue culture plastic.  Once the 
tissue sheet was contracted, the flask was fixed using 70% ethanol and stained with Trypan Blue. 
Figure 7-14 is an image of a stained flask after induced tissue sheet contraction using K-PSS. It 
can be seen that most of the tissue sheet in the majority of the flask was contracted, with only a 
patch of tissue around the neck region of the flask remaining. 
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Figure 7-14 Flask stained with Trypan Blue after tissue sheet contraction using 
K-PSS 
To translate these results to our cell tubes, we determined the approximate cell seeding 
surface area of our tubes and converted the cell density accordingly.  This density, 250,000 
cells/tube was then injected into several cell culture tubes and rotated by hand as previously 
described.  At 48 hours, the media in the tubes was replaced and the tubes were replaced in the 
incubator to continue growing.  After 72 hours, the media in the tubes was replaced with K-PSS 
and the tubes were incubated until contraction occurred.  It was found that the K-PSS caused 
tissue to contract off of all tubes within 30 minutes.  In particular, we found that a portion of one 
tube contracted radially and actually attached to the inner mandrel to form a small tissue tube as 
shown in Figure 7-15. This result shows that our cell density experiments have found a correct 
density and seeding period that can form tissues through cell contraction with K-PSS. 
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Figure 7-15 Tissue tube contracted around entire diameter of central mandrel 
Using these results, the final design was assembled and tested. Each tube was seeded with 
a density of 250,000 cells/tube and the cell culture stand was rotated approximately 1 
revolution/hour for 2 hours using the rotation system. The entire device was placed within the 
incubator as shown in Figure 7-17.After two hours, the rotation system was separated from the 
cell culture stand and removed from the incubator.  
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Figure 7-16 Tissue culture stand placed on automatic rotation inside the 
incubator 
Due to difficulty in containing leaks, the pump system was not utilized and cells were fed 
manually using syringes at 48 hours. At 72 hours the sheets were harvested by completely 
replacing the media via injecting K-PSS into the culture chamber. Within 30 minutes, the 
majority of the tissue had contracted off of the glass tube wall. However, rather than contracting 
as a continuous sheet, the tissue sheet tore into smaller pieces and contracted off the tube as 
individual ―flakes‖.  Figure 7-17 shows an image of a ―flake‖ of tissue contracting off of the 
glass tube. This outcome is most likely due patches of dead cells caused by air bubbles that 
formed within the glass tube chamber. These dead patches cause stress concentrations due to 
uneven sheet thickness resulting in tearing during contraction. Furthermore, an uneven 
distribution of contractile proteins within the cell sheet would also result in non-continuous sheet 
contraction. 
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Figure 7-17: Tissue flake after tissue contraction using K-PSS solution. 
7.4.3. Fluid flow 
Fluid flow testing used the media flow system described earlier in this section. The tubing 
system and manifolds used to divide media input to each cell culture tube were tested to ensure 
even fluid flow. A dyed water solution was used to better visualize the fluid flow. This solution 
passes from the Pyrex bottle, which acts as the media reservoir, through the tubing structures and 
a peristaltic pump. Eventually the fluid reaches a set of two manifolds that divide the tubing into 
eight separate pathways. Each pathway leads to a 15 mL conical tube to collect the output 
solution and then observed for equal rates and quantities. The final volumes in the conical tubes 
were similar at the end of the experiment, although not perfectly equal.  
Ideally, the fluid flow would be even to prevent any differences in flow between tubes, 
however uniform media flow to each cell culture tube was difficult to achieve. Even flow is 
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critical when contracting the tissue sheets off of the outer tubes because the K-PSS is injected 
into the tubing directly upstream of the glass seeding tubes. If unequal amounts of K-PSS reach 
the tubes, some tubes may contract fully while others only contract partially or not at all.  
The design team experienced considerable difficulty creating even fluid flow through each of 
the glass culture tubes. This problem was likely due to the air that initially was in the tubes 
before flow begins. The air bubbles seem to prevent fluid flow down a tube and therefore some 
tubes receive a large volume of fluid while others receive little. In order to overcome this 
problem, the team attempted to completely fill the tubing with fluid before activating the pump. 
Media was systematically injected into segments of the tubing blocked off by tubing clips and 
stop-valves. In this way, the team attempted to ensure that the tubing and cartridge were filled to 
capacity with media, instead of estimating the volume of media the entire system contains and 
filling it all at once. Additionally, this allowed the team to observe any problems encountered by 
the fluid flow in each segment, providing an opportunity to make any adjustments necessary. The 
team also tried forcing fluid down each of the tubes while withdrawing air to create a vacuum, 
such that the air can be removed as the volume is replaced with media; however these methods 
were largely ineffective at avoiding leaks and air bubbles trapped in the tubing during media 
flow.  
While each of these methods improved on the results of fluid flow, neither was able to create 
the flow through all of the tubes. It may be possible that the process of piercing through the 
PDMS of the cell culture cartridge, or the ports to the media reservoir which introduce a breach 
in the system that should be otherwise airtight. In this case, an alternate method of sealing the 
glass culture tubes onto the vessel or sealing the tubes leading into the media reservoir may be 
effective at eliminating fluid flow issues in the future.  
  
77 
 
8.0 Conclusions and Recommendations 
Although each individual component of our device was conceptually shown to work, there 
is still room for improvement through future research and development. Conclusions made from 
our research, as well as future recommendations for the advancement of our device will be 
discussed in this chapter. 
8.1. Design Considerations 
As with any design project, the larger societal impact of this project and its outcomes must 
be examined and discussed. In this section we will analyze the impact of this project on various 
aspects of the world around us. 
8.1.1. Economic Impact 
If the device is successful in growing tissue tubes, a large amount of lives could be saved 
by using the products of this device to replace native diseased arteries. Heart disease remains the 
leading cause of death in the United States. If a successful graft is grown, people would be 
healthier longer and be able to remain in the workforce longer creating a positive economic 
impact.  
With FDA approval, autologous grafts would not be needed which would minimize the 
cost of a second surgery. Any complications and extended stay from a second surgery would also 
be eliminated. Furthermore, the number of heart transplants would be reduced due to diseased 
arteries being replaced before any cardiac event happens. This would save money on the costly 
procedure of a heart transplant and any immunosuppressant drugs that would be needed for the 
rest of the patients’ life.  
 The device could also generate jobs in Tissue Engineering research, product 
manufacturing and in sales. Since there is essentially no product on the market except for the 
Lifeline graft, the growth of this market could be immense.  
8.1.2. Societal Impact 
Based on the aging population and the high instance of coronary artery disease in the 
population today, tissue engineering has a large opportunity to impact society. With the 
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development of a completely tissue engineered blood vessel, an increase in life expectancy 
would likely be seen. The tissue tubes could be used to restore blood flow to infarct areas of the 
heart after heart attacks.  Based on this information, the potential societal impact is substantial 
with the development of a tissue engineered blood vessel. 
8.1.3. Ethical Impact 
Due to its recent growth in public awareness, the field of tissue engineering is increasingly 
becoming a subject for debate on ethics.
34
  To some, Tissue Engineering is a step in the right 
direction in that it attempts to solely use cells derived from nature.  Others, however, identify the 
use of cells outside of the body to create ―body parts‖ as a direct violation of nature, and 
therefore unethical.  Although we have only used somatic cells derived from rats thus far in the 
design and testing of our project, we must address the fact that the eventual intent of this project 
is to produce tissue tubes from human cells.  This practice, which is considered morally suspect 
by many religious groups
35
, would make the use of our project controversial if it were ever used 
in a clinical setting.   
To support those who disagree with tissue engineering, while not denying the benefits of 
our project from those who accept it morally, we recommend that patients receiving the benefits 
of our project receive informed consent.
35,36
  This concept, which has been supported by previous 
studies
35
, requires that patients are informed of the origin of all tissues that are implanted in them 
prior to receiving surgeries.  This approach simply and effectively appeases both sides of the 
issue and gives patients the power to make decisions based on their own ethics and beliefs. 
8.1.4. Health and Safety 
With regards to health and safety, it is imperative that the device be readily sterilized to 
ensure that the vessel produced is free from contaminates. As such, it would be wise that the 
bioreactor be composed of a number of parts that may be disassembled to allow for cleaning. 
Also, these parts must be composed of materials that can be cleaned without being damaged. It 
would also be important for the bioreactor to be controlled for media circulation and gas 
exchange to allow minimum exposure to elements outside of the desired of the system. 
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Finally, the design must ensure that the user interface provided minimizes contact with the 
vessel or media and does not pose any bodily threat to the user, (infection, electrocution, burns 
etc.) 
8.1.5. Manufacturing 
In order to design for manufacturing, the device will the composed of parts that are 
widely commercially available as well as economical. Each part of the device will be chosen to 
be as mechanically simple as the design will allow, while minimizing the number of parts used in 
total. The device will be assembled in a manner that is comprehensive and reproducible for 
future replication. 
8.1.6. Environmental Impact 
With respect to the environment, all parts used will be of materials that are minimally 
hazardous to the environment and of materials that do not produce any toxic waste-products. To 
minimize environmental impact, we have chosen materials that can be sterilized and reused 
through several seeding cycles.  The device was designed such that all materials are conserved 
and eventually disposed of in a suitable manner by following OSHA and EPA regulations for 
biohazard disposal. Any power necessary for running the device will electric, and may produce 
by-products known to be harmful to the environment depending on the source of the electricity. 
Depending on the manufacturing company contracted to build and distribute the device, large-
scale production of the device may be responsible for greenhouse gas emissions due to industrial 
and transporting processes. 
8.2. Conclusions 
The preliminary testing of a novel method for three-dimensional cell culture shows that 
tissue tubes may be produced by seeding cells into a cylindrical tube and contracting the cultured 
tissue sheet onto an inner mandrel.  This method is superior to previous methods in that the 
tubular device allows for adequate cellular adhesion without the use of a coating, which has been 
difficult and time consuming in the past. Additionally, due to the contractile nature of smooth 
muscle cells and the cellular response to K-PSS buffer, the vessel produced may be contracted 
onto a mandrel once confluence has been achieved.  This would allow researchers to create tubes 
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of various wall thicknesses based on culture time and seeding density, in order to optimize tissue 
properties.  Following tissue contraction, the vessel can be easily removed from the inner 
mandrel and conditioned for desired mechanical tissue properties.  
This method of culturing cylindrical tubes offers many advantages over the current 
hanging drop method which is limited to seeding cells onto only one side of a mandrel at a time. 
Vessels produced in this manner are often non-uniform in cell thickness axially, as this method is 
by and large a two-dimensional approach. Inconsistent wall thickness results in uneven stress 
concentrations in the vessel wall, which compromises the vessel’s mechanical integrity. Seeding 
cells into a cylindrical tube and rotating the tube applies the same concept of directing cell 
attachment but approaches it in a three-dimensional sense. By allowing cells to adhere to one 
another freely along a continuous inner surface, one can produce a tissue sheet cylindrical in 
shape without the uniformity issues associated with the hanging drop method.  
The hanging drop method also requires the use of a mandrel coated with collagen, which 
promotes cellular adhesion to the mandrel.  The procedure of coating the mandrels used in the 
hanging drop method is especially labor-intensive and often produces mandrels with 
imperfections, such as air bubbles, rendering the products unusable. The method developed by 
the current research produces grafts that are free of artificial adhesives. This greatly decreases 
the time required to set up a device that is able to grow tissue engineered blood vessels. 
Additionally, the reproducibility of viable tubes is greatly increased due to the decrease of 
possible imperfections in the tubes produced. 
The success and simplicity of this method allows the entire process to be altered in a few 
ways to better meet the client’s needs. First of all, the device can be ―scaled-up‖ and may 
produce several scaffold-free tissue tubes at once. Initially the device could only produce one 
tube at a time. The current design, however, allows for up to eight tubes to be grown at a time. 
This increases the likelihood that viable tubes will be produced with each ―batch‖ that is seeded. 
Secondly, the completely contained fluid flow system provides many advantages in this design. 
For example, the fluid flow rates in the bioreactor can be adjusted based on the pump speed and 
the tubing setup. This allows for a sufficient and equal amount of media to be supplied to each 
tube. This ensures that any differences in the tissue tubes produced are not due to insufficient 
media supply. The complete pumping system is also an added benefit because it helps to 
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automate the process, which decreases the work required by the operator. It is completely self-
contained, which provides a sterile environment within which cells may be seeded and cultured.  
Ports are also provided in the bioreactor so that at the appropriate time K-PSS may be 
administered without disrupting the sterility of the media flow system. The entire assembly is 
small enough and compatible for use directly inside an incubator.  
Based on the results of the conceptual testing described above, this device shows great 
promise in producing tissue tubes with the potential for use as vascular grafts. While more 
research is needed to perfect this approach, we believe that the device has the potential to impact 
the future of tissue engineered vascular grafts for use in arterial bypass surgeries. As described in 
previous sections of this chapter, the impact of this device may have implications reaching far 
beyond the field of tissue engineering. 
8.3. Recommendations 
 Given more time and a larger budget, this design could be improved in several ways.  The 
following sections include some of the suggestions the design team has for future researchers 
using or expanding upon our device. 
8.3.1. Device Construction 
Although our device is more time and labor efficient than the method currently used in the 
Rolle lab, we believe that our design could be further optimized to decrease the labor and time 
required in its construction.  The main change we think could be making the seeding tubes more 
easily removable from the seeding cartridge.  This change would allow the tubes to be more 
easily viewed under the microscope throughout the seeding process. Additionally, we would 
recommend replacing PDMS connections with a more easily disassembled connector that still 
retains the sterility of the tubes. 
8.3.2. Cell Seeding Optimization 
In our early cell seeding experiments, we compared low concentration with high 
concentration cell seeding.  During these experiments we determined that seeding our cells at a 
lower concentration for three days produced more robust tissue sheets than seeding at higher 
concentrations for a shorter period of time.  Given more time and resources, we would have liked 
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to have tested more concentration and seed time alternatives to further deduce the most effective 
concentrations.  Additionally, altering culture conditions, such as the concentration of fetal 
bovine serum in the media, could improve the structural properties and mechanical functions of 
the tubes being produced.  
8.3.3. Fluid Flow System 
During our project, we designed a low flow pump and tubing system to provide constant 
media exchange to our cell seeding cartridge.  Although this system worked conceptually during 
non-sterile tests for even flow, we found that trying to use this system during an actual tube 
seeding process was not feasible.  Due to space constraints in a cell culture hood and incubator, 
and time constraints required to keep our cells at optimal temperatures, we found that the system 
was hard to connect and manage.  As a result, we recommend that a new system be developed to 
provide the bioreactor portion of our design.  Specifically, to increase the effectiveness of this 
system, the cell culture tubes should be redesigned to connect directly to the pump tubing. 
8.3.4. NIPAAM 
Based on the ineffective tissue tube removal methods described previously, this device 
could be greatly improved by using a consistent and deliberate tube removal method. One 
possible approach that could be taken in the future is the use of NIPAAM (N-
isopropylacrylamide), which is a thermo-responsive polymer that can be used to coat cell culture 
surfaces. NIPAAM is hydrophilic at 37°C (the temperature used for incubation during cell 
culture) but becomes hydrophobic when the temperature drops below 32°C. Therefore, if cells 
are cultured on a NIPAAM coated surface, they will adhere to the surface, proliferate, and 
eventually form a confluent sheet across the surface area. Then, once the temperature is lowered 
below 32°C, the surface becomes hydrophobic and the cell sheet releases from the surface and 
remains in sheet form due to the cell derived extracellular matrix. A schematic of this process is 
seen below in Figure 8-1. 
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Figure 8-1: Schematic representation of the thermo-responsive polymer 
NIPAAM used as a surface for cell seeding. As seen above, a temperature 
change from  37°C to 32°C will release the cells from the seeding surface.37 
The team completed preliminary testing of NIPAAM using an UpCell 24-well plate made 
by Thermo Scientific. As described in Appendix D, the wells were seeded with fifteen thousand, 
thirty thousand, or sixty thousand cells and allow to culture for 72 hours. The plate was then left 
at room temperature for 30 minutes while being observed. At this time, there was no noticeable 
change in the appearance of the tissue sheets. Therefore it was cooled using an ice bath. After 
being cooled for 5 minutes, it was noticeable in some areas that the tissue sheet had released 
from the surface. A picture taken during this time is seen below in Figure 8-2. 
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Figure 8-2: A contracting cell sheet on an UpCell NIPAAM coated plate. This 
well was seeded with sixty thousand cells and allowed to culture for 72 
hours. 
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Appendix A: Pairwise Comparison Charts 
Top Objectives 
 Bioreactor Cell Seeding Mandrel Material Score 
Bioreactor  0 0 0 
Cell Seeding 1  0 1 
Mandrel Material 1 1  2 
 
Bioreactor 
 Automatically 
Supply media 
Fits into 
incubator 
Can be 
sterilized 
Physiological 
Environment 
Score 
Automatically 
Supply media 
 1 1 0 2 
Fits into 
incubator 
0  0 0 0 
Can be 
sterilized 
0 1  0 1 
Physiological 
Environment 
1 1 1  3 
 
Cell Seeding 
 Stick evenly to 
mandrel 
Grow and support 
own ECM 
High success rate Score 
Stick evenly to 
mandrel 
 0 1 1 
Grow and support 
own ECM 
1  1 2 
High success rate 0 0  0 
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Mandrel 
 Cells 
Stick to 
mandrel 
material 
Mandrel 
can be 
removed 
from 
TEBV 
Keeps 
TEBV 
ends 
open 
Can be 
Sterilized 
Cells 
don’t 
integrate 
with 
mandrel 
material 
Minimize 
material 
costs 
Biocompatible 
Material 
Score 
Cells Stick to 
mandrel 
material 
 0 0 0 0 1 0 1 
Mandrel can 
be removed 
from TEBV 
1  0.5 0 0 1 0 2.5 
Keeps TEBV 
ends open 
1 .5  1 0 1 0 3.5 
Can be 
Sterilized 
1 1 0  0 1 0 3 
Cells don’t 
integrate with 
mandrel 
material 
1 1 1 1  1 1 6 
Minimize 
material costs 
0 0 0 0 0  0 0 
Biocompatible 
Material 
1 1 1 1 0 1  5 
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Appendix B: Functions-Means Trees 
Bioreactor 
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Cell Seeding 
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Mandrel Material 
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Appendix C: Preliminary Experimental 
Protocols 
Testing Protocols:  
I. Tissue-sheet culture 
 1. Optimizing serum concentration 
  Materials- 
   Tissue culture flasks 
   FBS, 2% and 10% 
   DMEM-solution 
   Ethanol 
   Trypan blue 
   hemocytometer    
  Procedure- 
1. Fill flasks with media. 
2. Inject flasks with cells. 
3. Allow to culture for 4 days and were fed with fresh DMEM as necessary, 
(based on metabolic rate assessed by media color).   
4. After 4 days, cells were fixed with ethanol and stained with trypan blue. 
5. A 40 μm sample was loaded onto hemocytometer and counted. 
 
II. Mesh Mandrel and Vacuum Testing 
1. Constructing Mesh Tubing 
Materials- 
   Mesh tubing, (34 µm pores) 
   Micropipette tips 
   Silicone glue  
 
Procedure- 
1. Roll mesh sheet onto micropipette tip. 
2. Apply silicone glue to side of tube.  
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3. Press tube wall together until glue sets. 
4. Repeat steps 2-3 until mesh layers are securely adhered.  
5. Repeat steps 1-4 for each tube.  
*Note: Bending mesh to make pre-formed creases helps secure layers.  
  
2. Constructing PDMS Plugs 
Materials- 
   Dow Corning® Sylgard 184 Silicone Elastomer kit: 
   PDMS 
   Curing agent 
   Syringe 
   96 well plate 
Procedure- 
1. Mix PDMS and curing agent at 10:1 ratio. 
2. Syringe into 96 well plate. 
3. Place item to be ―plugged‖ into PDMS well.  
4. Place in incubator at 60OC and allow setting for an hour.  
5. Repeat steps 3-4 for each plug. 
 
3. Procedure for Mesh Experiment 
 Materials- 
  Mesh tubes 
  PDMS 
  RSMC-solution 
syringe 
 Procedure- 
1. Plug one end of mesh tube with PDMS. 
2. Seed 1 mL, (9,825,000 cells) of cell solution into tube with syringe. 
3. Incubate for 24 hours.  
4. Vacuum design 
Goal: Determine if vacuum will increase cell adhesion on mandrel. 
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Control: Mandrel without vacuum.  
 Materials- 
  Polysulfone mandrels 
  Hypodermic needle 
  3 mL syringe 
  Petri dish 
  Media 
  70% EtOH 
 Procedure- 
1. Sterilize materials with 70% EtOH and place in biosafety cabinet 
2. Fill petri dish with media  
3. Manually pinch on end of mandrel and insert needle, and draw media in through 
mandrel by pulling back on the syringe 
4. Allow to incubate for 1-2 weeks, checking and feeding as necessary 
5. Verify cell adhesion by submerging and staining with Trypan blue. Observe 
results under microscope.  
 
 Sterilize materials (chamber, pump, mandrels)   
 Hook up pump to the mandrel via silicone tubing and clamp down 
 Clamp down one end of mandrel to create vacuum 
 Circulate medium by putting inlet of pump into chamber 
 Add ___cells to ___ml of medium 
 Add media to culture chamber 
 Turn on pump for ___ml/min 
 Put bioreactor into incubator  
 After ___ hours, take chamber out  
 Count cells via stripping off mandrel, or adding fluorescent Hoechst dye to mandrel 
itself. 
 
 
III. Glass Tube Reactors  
1. Optimizing cell density and culture time 
  
96 
 
Materials- 
 5 mL glass pipettes  
 Metal file 
 RSMC-solution 
 Syringe 
 DMEM 
Procedure- 
1. Pipettes were scored and broken into tubes of approximately 7.0 cm. 
2. Plug ends with PDMS. 
3. Inject tubes with RSMC-solution, (16 million cells/ 75 cm2, or 0.402 
million * L) and allow to culture for 4 days. 
4. Tubes were rotated ¼ of a turn every hour. 
5. Cells were fed with 3.0 mL of fresh DMEM each day.  
*This experiment was repeated with various cell densities, culture 
times, and rotational frequency.  
 
2. Pyrex Tube Rotational Seeding 
Materials- 
  5 mL pyrex glass pipette tube 
  Steel file 
16 millions cells/75 cm
2
 cell solution 
Media prepared with 10% FBS 
petri dish 
PDMS 
Hypodermic needle 
3 mL syringe 
Autoclave 
scissors 
Procedure- 
1. Prepare 9 cm glass tubes by scoring with steel file and snapping them. 
2. Plug ends with PDMS as described on pg. 87, (PDMS plugs) 
3. Create stand for tubes by cutting edge of petri dish.  
4. Sterilize tubes in autoclave and use hypodermic needle to inject with cell 
solution to capacity. Mark tubes every ¼ length of circumference. 
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5. Place in petri dish and allow to culture for 2 hours. Turn tube a quarter turn 
every ½ hour.  
6. Allow tube to culture for additional 48 hours. Remove from incubator and 
observe for confluency.  
 
IV. Pinball cell-seeding probability 
 1. Cell motion visualization 
  Materials- 
   Petri dish 
   Pepper 
   Water 
   Silicon tubes 
   Silicon glue 
 Procedure- 
1. Cut silicon tubing short enough to fit within closed Petri dish. 
2. Glue tubing to bottom of Petri dish. 
3. Fill with water and pepper. 
4. Place lid on dish, seal with silicon glue. Allow to set for an hour. 
5. Shake disk, observe pepper-motion. 
 
2.  Cell seeding success rate 
 Materials- 
   Petri dish 
   RSMC-solution 
   Silicon tubes 
   Silicon glue 
   Trypan blue 
   DMEM 
   Fetal bovine serum, (FBS) 
   Ethanol 
   syringe 
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  Procedure- 
1. Cut silicon tubing to height of Petri dish. 
2. Glue to bottom of dish with silicon glue. 
3. Create hole in lid of dish and plug with PDMS. 
4. Spray with ethanol and place in UV light to sterilize. 
5. Coat Petri dish lid with FBS. 
6. Seal Petri dish with silicon glue, allow setting for an hour.  
7. Inject cell solution through PDMS plug with syringe and culture for 5 
days. 
8. Cells were fed with fresh DMEM twice during the culture period.  
* Experiment was repeated and tested for the various cell densities.  
 
V. Washing Machine FLUENT modeling 
 1.  Fin-shape evaluation 
  Materials- 
   ANSYS Suite, FLUENT modeling program 
   Lab PC 
  Procedure- 
1. Model fin array in FLUENT. 
2. Generate mesh. 
3. Specify solution conditions:  
Solver = pressure-based 
Velocity formulation = absolute 
Time= steady 
Gravity = -9.81 m/s
2
 on the y-direction 
Multiphase model- Eulerian with 1 phase 
 Parameter=Dense Discrete Model Phase Model, 1 phase 
Volume fraction= implicit 
Discrete phase = on 
Fluid= serum 
 Density= 1000 kg/m
3
 
 Viscosity = 0.385 kg/m
3
 
 
  
Temperature reference= 298.15 K 
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Solid= aluminum 
 Density = 2719 kg/m
3
 
Inert particle= anthracite 
 Density= 1550 kg/m3 
4. Initialize and run calculation for 100 interations. 
5. View results and analyze velocity vectors.  
 
VI. Tissue Tube contraction in the cell culture vessel 
1. KCl contraction 
 Materials- 
  Pyrex cell culture vessels 
  Media prepared with 10% FBS  
  Media prepared with 2% FBS 
  KCl solution with 10% FBS 
  Hypodermic needles 
  3 mL syringe 
  Petri dish stand 
 Procedure- 
1. Prepare pyrex tubes by plugging with PDMS, as previously described 
2. Inject culture vessel with cell solution and media and place in petri dish stand 
3. Rotate vessel 1/8 of a turn every 10 minutes for 2 hours in incubator. Allow to 
culture for an additional 48 hours.  
4. Observe for confluency and feed cells as needed.  
 
VII. K-PSS contraction 
1. Observing contraction rates of tissue sheets at different cell densities 
Materials- 
  2- 75 cm
2 
flasks 
  Media with 10% FBS 
  2 mL of 1 million cells/mL solution in each 
  60 mM K-PSS solution 
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  60 mM PSS solution 
Procedure- 
1. Allow to culture in flasks in  incubator for approximately 72 hours or until confluency 
is observed.  
2. Aspirate media from flasks and rinse with 10 mL PSS, as a control. 
3. Return flask to incubator and check every 20-30 minutes for contraction. 
4. Repeat Steps 2-3 for K-PSS.  
 
2. K-PSS contraction in the cell culture cartridge 
Materials- 
  3 mLof 1 million cells/mL solution 
  Media prepared with 10% FBS 
  Cell cu lture cartiridge  
  automated rotation system 
  hypodermic needles 
  3mL syringe  
Biosafety cabinet 
70% EtOH 
Procedure- 
1. Hold cartridge vertically and inject culture vessel with media and cell solution from 
bottom of chamber. Pierce through PDMS using hypodermic needle. Repeat for each 
culture vessel. 
2. Place cartridge onto gear system, place device into incubator, and start rotation. 
Allow cartridge to rotate in incubator for 2 hours.  
3. Remove device from incubator, and remove cartridge from system. Replace cartridge 
to incubator and allow to incubate for an additional 72 hours.  
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4. Remove cartridge from incubator and place in sterile biosafety cabinet.  
5. Sterilize hypodermic needles syringe and media containers. 
6. Aspirate media from each culture chamber and fill with K-PSS.  
7. Return to incubator and check for contraction every 20-30 minutes.  
 
VIII. Final Design Assembly 
1. Timing the rotisserie system 
 Materials- 
  Mr. Flame rotisserie system 
  Cell culture cartridge 
  Rotational Force transducer 
  Rubber band 
  LabView computational program 
  Lab PC 
  D-battery 
 Procedure- 
1. Setup LabView for data acquisition of rotation force transducer using lab PC 
2. Slide cell culture cartage onto rotisserie spit and plug shaft into Mr. Flame motor. 
Be sure that motor is supplied with a D-battery. 
3. Wrap a rubber band around the spit and around the smaller radius knob on the 
force transducer 
4. Start rotation, and begin data acquisition.  
5. Interpret rotational speed from angular position graph. 
 
2. Assembling the gear system 
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 Materials- 
  Vex gears and system components: 
   Screws 
   Collars 
   Motor shaft 
   Sheet metal supports 
   Plastic washers 
   Allen wrench 
  Mr. Flame rotisserie stands 
  Vertical band-saw 
  Metal file 
  Polycarbonate sheet 
  Rubber grip  
 Procedure- 
1. Use 3 sets of 84-tooth to 12-tooth gear ratios to create 343:1 gear ratio 
2. Place small gear on Mr. Flame motor output shaft. Use small gear to drive a large 
gear with another smaller gear on the same shaft. 
3. Allow smaller gear to drive another larger gear, with another smaller gear on the 
same shaft.  
4. Allow smaller gear to drive another larger gear. 
5. Place smaller gear on rotisserie spit and align stands such that the gears make 
adequate contact and the spit can be still be removed.  
6. Affix gear system to sheet metal supports using screws and tightening with an 
allen wrench. Place plastic collars on gear shafts before securing so that gears 
with rotate smoothly. 
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7. Use vertical band saw to cut Mr. Flame stands to appropriate height and file edges 
until smooth 
8. Cut rubber grip material into four squares and glue to bottom corners of 
polycarbonate sheet to increase traction on bench surface and reduce slip. 
9. Secure gear system and stand to polycarbonate sheet using hot glue and secure 
gear system with screws 
 
3. Assembling the Cell Culture Cartridge 
 Materials- 
  Rapid prototyped octagonal stands  
  Rapid prototyped ―table‖ component 
  Duct tape 
  PDMS 
  Silicon glue 
  8- 9 cm stainless steel mandrels 
  8- Pyrex glass cell culture tubes 
  IsoTemp oven 
 Procedure- 
1. Block injection holes with duct tape 
2. Score and cut pyrex tubes as previously described. 
3. Score and snap 8- 9 cm stainless steel mandrels from original length received 
4. Place pyrex tubes and mandrels into each designated hole in the octagonal stand. 
Use the table to hold and align the mandrels. 
5. Fill each space surrounding the tubes with PDMS and seal with silicon glue. 
Allow to cure in IsoTemp oven at 60°C for approximately 1 hour. 
  
104 
 
6. Invert structure and align tubes and mandrels into designated holes on other 
octagonal stand.  
7. Repeat Step 5 and sterilize in autoclave prior to use.  
 
4. Assembling the Fluid Flow System 
 Materials- 
  1 L pyrex container 
  5 mL pipette tips 
  3- Tubing stop-clips 
  Luer fittings: 
   2- Injection port fitting 
   2- 4-way manifolds 
   4- 6-way manifolds 
   3-way stop-valve 
   4- Stop-fittings, (plugs) 
   Silicone tubing 
  50 mL beaker 
  Tape 
  Low-flow peristaltic pump 
  Media 
  60 mL syringe 
 Procedure- 
1. Pierce cap of Pyrex bottle and insert 2- 5 mL glass pipette tubes. Seal with PDMS 
to act as media reservoir.  
2. Slide stop clip onto tubing and attach to pipette tube in reservoir.  
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3. Attach injection port fitting directed away from the media reservoir.  
4. Attach an additional length of tubing and run it through the peristaltic pump 
5. Attach end of tubing to 4-way manifold and plug center vessel with luer stop-
fitting.  
6. Attach lengths of tubing to each remaining vessel pathway and attach each end to 
a 6-way manifold. Plug vertical vessel pathways with stop-fittings. Connect 
remaining vessels pathways to segments of tubing leading to the cell culture 
cartridge. 
7. Repeat Steps 2-3 for remaining pipette tip of the media reservoir. 
8. Wrap lengthof tubing around 50 mL beaker and secure with tape to act as gas 
exchange coil. Connect one end to remaining injection fitting. 
9. Slide a stop-clip onto free end, and attach to 3-way stop valve.  
10. Connect stop-valve to additional segment of tubing and repeat Steps 5-6.  
11. Use injection portals, stop valves, and tube clips to systematically fill segments of 
the system with media using the 60 mL syringe.  
     
5. Seeding cells in the cell culture cartridge with the automated rotation system 
Materials- 
 Modified rotation system 
 Cell solution 
 Media prepared with 10% FBS 
 Hypodermic needles 
 3 mL syringe 
 70% EtOH 
 biosafety cabinet 
Procedure- 
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1. Sterilize gear system and materials using 70% EtOH and place in biosafety cabinet 
2. Use hypodermic needle and 3 mL syringe to seed cell culture vessels in cartridge as 
previously described. 
3. Place cartridge onto rotation shaft and onto rotation system 
4. Place rotation device and cell seeding assembly in incubator and run rotation for 2 
hours 
5. Remove from rotation system from incubator and return cell seeding cartridge to 
incubator and allow to culture an additional 48 hours.  
 
IX. NIPAAM experiment 
1. Goal: Evaluate cell-growth on NIPAAM 
Experimental group: NIPAAM coated TCPs, (UpCell 24-well plates) 
Materials- 
 24-well UpCell plate 
 15,000 cell/well solution 
 30,000 cell/well solution 
 60,000 cell/well solution 
 Micropipetter 
 Incubator 
 Icebath 
Procedure- 
1. Cell concentrations of 15,000 cells/well, 30,000 cells/well and 60,00 cells/well were 
prepared.  
2. Cell solutions were pipetted into 8 wells each and incubated for 72 hours. 
3. Cells were observed under a microscope for confluency.  
4. Cells were placed in an icebath at 2.7° C for 5 minutes and then moved to a microscope 
to observe contraction. 
 
 
  
107 
 
Appendix D: Bill of Materials 
Stand 
 
Part Number Part Description Units Company Cost 
Custom Octagonal Stand  1 (two pieces) WPI Mechanical 
Engineering Dept. - 
Rapid Prototyping 
$41.40 
 5mL Pyrex Glass 
Pipettes cut to 9cm 
sections 
8 pieces per 
device 
WPI Biomedical 
Engineering Dept. 
 
 
 
 
309603 5mL Syringes 2 per seeding B-D  
305176 Hypodermic 
Needles 
16 per device 
 
B-D 
 
 
364116- 
000010 
Silicon Glue 
 
1 tube Dow Corning  
(400)00010 
4511207 
PDMS Kit 1 kit Dow Corning  
B000HZX47O Stainless Steel 
Centerless Ground 
Rod  
1 pack of 
72inches 
Small Parts, Inc. $9.40 
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Rotation System 
 
Part Number Part 
Description 
Units Company Cost 
53767 Mr. Flame 
Rotisserie 
1 Aqua Superstore $22.99 
Varies based on 
desired rotation 
speed 
Vex Gears 5 (various sizes) WPI Electrical 
and Computer 
Engineering 
Dept. 
 
Scrap Piece Polycarbonate 
Base 
1 Plastics 
Unlimited 
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Pump System 
 
Part Number Part Description Units Company Cost 
13-876-1 
Model 3385 
Peristaltic Pump 1 Fisher Scientific  
Various Luer Fittings Various WPI Biomedical 
Engineering Dept. – 
Luer Fittings Kit 
 
6PTT230-6 Six-port Thru Flow 
Manifolds 
100/pack  Value Plastics, Inc. $45.00 
13162-100 Male Luer Fitting 
1/8‖ID 
100/pack World Precision 
Instruments, Inc. 
 
Custom Media Reservoir 1 Materials from WPI 
Biomedical 
Engineering Dept. 
 
 
 
 
B000FN1I9Y Silicone Med-X 
Tubing 
1 pack (50 ft.) Small Parts, Inc. $57.45 
 
 
 
